<SEC-DOCUMENT>0001140361-20-023403.txt : 20201020
<SEC-HEADER>0001140361-20-023403.hdr.sgml : 20201020
<ACCEPTANCE-DATETIME>20201020160521
ACCESSION NUMBER:		0001140361-20-023403
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20201015
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201020
DATE AS OF CHANGE:		20201020

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES, INC.
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12421
		FILM NUMBER:		201248330

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-1000

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ENTERPRISES INC
		DATE OF NAME CHANGE:	19980909

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10016052_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:nus="http://nuskin.com/20201015" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_8dbd2699d2e4444286e282352ec98c3d" contextRef="c20201015to20201015" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_8ef496a892794eb4927adc4f8c76e8d8" contextRef="c20201015to20201015">0001021561</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="nus-20201015.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20201015to20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001021561</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-15</xbrli:startDate><xbrli:endDate>2020-10-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_8da9aac50b354fb39b6968f88059ef9d" contextRef="c20201015to20201015">8-K</ix:nonNumeric></div>

      <div><br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z68b72695b0c1422293f131c19cce6d12">


  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_055bcfa46dd94f1fa40e7e92e7d399f8" contextRef="c20201015to20201015" format="ixt:datemonthdayyearen">October 15, 2020</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top; width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Date of Report (Date of earliest event reported)</div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="vertical-align: top; width: 65%;">&#160;</td>

    <td rowspan="1" style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 24pt;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_4b2d3484934c47878b9d9b4999ce3c28" contextRef="c20201015to20201015">NU SKIN ENTERPRISES, INC.</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top; width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Exact name of registrant as specified in its charter)</div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 23.37%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_7241a0acc4c948dea60b6ffe9ad21273" contextRef="c20201015to20201015" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span><br />
            </td>

    <td style="width: 13%; vertical-align: bottom;">&#160;</td>

    <td style="width: 26.56%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_4e96305dfcce4ec59ebe8da70818c785" contextRef="c20201015to20201015">001-12421</ix:nonNumeric><br />
            </td>

    <td style="width: 13.64%; vertical-align: bottom;">&#160;</td>

    <td style="width: 23%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_ad535828e7cb4ef89d7d0b8cb37c701b" contextRef="c20201015to20201015">87-0565309</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 23.37%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 13%; vertical-align: top;">&#160;</td>

    <td style="width: 26.56%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Commission File Number)</div>
            </td>

    <td style="width: 13.64%; vertical-align: top;">&#160;</td>

    <td style="width: 23%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(IRS Employer Identification Number)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_114703ad83f34578b2d272f717163c48" contextRef="c20201015to20201015">75 West Center Street</ix:nonNumeric><br />
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4dd029fd3db14b0a8f9ddac5a31ba1d3" contextRef="c20201015to20201015">Provo</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_4d4d6b125c2a422fb17de756cb5b3b15" contextRef="c20201015to20201015" format="ixt-sec:stateprovnameen">Utah</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_468b32d651104793a4195d46a205564d" contextRef="c20201015to20201015">84601</ix:nonNumeric></div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top; width: 65%;">
              <div style="text-align: center;">(Address of principal executive offices and zip code) <br />
              </div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="vertical-align: top; width: 65%;">&#160;</td>

    <td rowspan="1" style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_4887830c26de48318e2d07eddf5ce18f" contextRef="c20201015to20201015">801</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_cffc4c4e3f424f7cb7814953659b0741" contextRef="c20201015to20201015">345-1000</ix:nonNumeric></div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top; width: 65%;">
              <div style="text-align: center;">(Registrant&#8217;s telephone number, including area code) <br />
              </div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 18%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="vertical-align: top; width: 65%;">&#160;</td>

    <td rowspan="1" style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">N/A</div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: top; width: 65%;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Former name or former address, if changed since last report)</div>
            </td>

    <td style="width: 17%; vertical-align: top;">&#160;</td>

  </tr>


</table>
      <div style="color: rgb(0, 0, 0);"> <br />
      </div>

      <div style="color: rgb(0, 0, 0);">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

      <div>&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z96013fb50a304522afd56f93ee6785c0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_9ff55eb04d6141329b6322aa62f500ae" contextRef="c20201015to20201015" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="color: rgb(0, 0, 0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7f8c59e2cfb8446fb3ff055072017806" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_bb11bce8095441b5a533f760624911ae" contextRef="c20201015to20201015" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
              </td>

  </tr>


</table>
      </div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2974c5ac69bd41babd4cd1775cc0fdd1">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_8fe41d7e3a4b47dab49567e5fc326cc5" contextRef="c20201015to20201015" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ade75236bd9492982ffc70fba1ac768">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_a8e76693d58541878981559dba3a1307" contextRef="c20201015to20201015" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="color: rgb(0, 0, 0);">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z86540b647289431b97a28e264d9c4039">


  <tr>

    <td style="width: 38.91%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
            </td>

    <td style="width: 19.26%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Trading Symbol(s)</div>
            </td>

    <td style="width: 41.83%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 38.91%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_657cdce137a1475f85ea682f07abfe79" contextRef="c20201015to20201015">Class A Common Stock, $.001 par value</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 19.26%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_fd9a6b950b8b4e3b82653ce2e415072f" contextRef="c20201015to20201015">NUS</ix:nonNumeric></td>

    <td style="width: 41.83%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_c6cc0d816d1b4a64b7f7682d541a49d7" contextRef="c20201015to20201015" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="text-align: right;"> <br />
      </div>

      <div style="text-align: right;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_0889afb9b06f4c3396420b30557b71ba" contextRef="c20201015to20201015" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="text-align: right;"> <br />
      </div>

      <div style="font-size: 12pt;"><span style="font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
          standards provided pursuant to Section 13(a) of the Exchange Act. </span>&#9744;</div>

      <div> <br />
      </div>

      <div>
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="page-break-after:always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze8b09ea1d6374902b265fdbcd4af1bb6">


  <tr>

    <td style="width: 72pt; vertical-align: top; font-weight: bold;">Item 5.02.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify;">(e)</div>

      <div><br />
      </div>

      <div style="text-align: justify;">At the direction of the Executive Compensation Committee (&#8220;Committee&#8221;) of the Board of Directors of Nu Skin Enterprises, Inc. (the &#8220;Company&#8221;), the Company entered into an employment agreement (the &#8220;Agreement&#8221;),
        effective as of October 15, 2020, with Joseph Y. Chang, Executive Vice President of Product Development and Chief Scientific Officer. Dr. Chang&#8217;s employment period under the Agreement will be October 15, 2020 to December 31, 2025 unless terminated
        earlier. The Agreement includes the following terms, among others:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfefaaa3617674b288afe8f8eda626182">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Compensation: Dr. Chang will receive a base salary, cash incentives, equity awards and other compensation, as determined by the Committee.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a69ccbbe5924aadabb38ea7fec036d5">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Vesting upon a change in control: Time-based equity awards granted to Dr. Chang will fully vest upon certain terminations of employment within six months prior to and in connection with, or within two years following, a change in
                control.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdb26475965c245ddb52c203dc35dcd55">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Severance payments: The Agreement provides that Dr. Chang will be added as a participant in the Company&#8217;s Executive Severance Policy, which will entitle him to receive various severance payments upon the occurrence of certain
                terminations of employment. The Committee amended the Executive Severance Policy accordingly on October 15, 2020. A description of the Executive Severance Policy is available in the Company&#8217;s Current Report on Form 8-K filed on March 14,
                2018.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d1148860f3d40cbb023262213f97497">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Consulting agreement: Upon the occurrence of certain terminations of employment, Dr. Chang and the Company will enter into a consulting agreement with a four-year term, the fees for which will be $287,500 per year less the amount of
                certain severance payments.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0e70d19271b64faf9c049a7e94c93a8b">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Employee covenants: Dr. Chang will be bound by employee covenants, including non-solicitation, non-competition and non-endorsement covenants.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify;">In addition, in view of Dr. Chang&#8217;s continued contributions to the Company, the Committee currently anticipates increasing the value of Dr. Chang&#8217;s annual equity incentive award from a value of approximately $710,000
        in 2020 to approximately $800,000 in 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify;">The foregoing descriptions of the Agreement and the Executive Severance Policy are not intended to be complete and are qualified in their entirety by reference to the full text of these documents, which are filed as
        Exhibits 10.1 and 10.2 hereto, respectively.</div>

      <div><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zcf5cd57f1a9e4c0ba71f1ec3b8b27a50" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 72pt;">
                <div><span style="font-weight: bold;">Item 9.01</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div><span style="font-weight: bold;">Financial Statements and Exhibits.</span></div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div>(d) Exhibits.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z31fca6f8cbe044aa8bd12342ebfae19c">


  <tr>

    <td style="width: 36pt; vertical-align: top;"><a href="brhc10016052_ex10-1.htm">10.1</a></td>

    <td style="width: auto; vertical-align: top;">
              <div>Employment Agreement between the Company and Joseph Y. Chang, effective as of October 15, 2020.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61775a696bf94a93ac2af5350ef8d5db">


  <tr>

    <td style="width: 36pt; vertical-align: top;"><a href="brhc10016052_ex10-2.htm">10.2</a></td>

    <td style="width: auto; vertical-align: top;">
              <div>Nu Skin Enterprises, Inc. Executive Severance Policy, amended and restated effective as of October 15, 2020</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z44d6b0dc13c5442b96491bfec51825b0">


  <tr>

    <td style="width: 36pt; vertical-align: top;">104</td>

    <td style="width: auto; vertical-align: top;">
              <div>Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="page-break-after:always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SIGNATURE</div>

      <div>&#160;</div>

      <div style="color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf7913f697b9a4ad081c7cf6abdbddabe">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">(Registrant)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 25%; vertical-align: top; border-bottom: 2px solid black;">
              <div style="color: rgb(0, 0, 0);">/s/ Mark H. Lawrence</div>
            </td>

    <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Mark H. Lawrence</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>

    <td rowspan="1" colspan="2" style="width: 50%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Date:&#160; October 20, 2020</div>
            </td>

    <td colspan="2" style="width: 50%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);"><br />
              </div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div><br />
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10016052_ex10-1.htm
<DESCRIPTION>JOSEPH CHANG EMPLOYMENT AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: SUMMIT
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="font-weight: bold; text-align: right;">Exhibit 10.1<br>
  </div>
  <div><br>
  </div>
  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EMPLOYMENT AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">THIS EMPLOYMENT AGREEMENT (this &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Agreement</font>&#8221;)

      is entered into effective as of 2020&#8209;10&#8209;15 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Effective Date</font>&#8221;) by and between Nu Skin Enterprises, Inc., a Delaware corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Company</font>&#8221;) and Joseph Y. Chang, an individual (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Executive</font>&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Executive has been employed since May 17, 1997 by the Company or one of its affiliates;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Executive and the Company entered into an Employment Agreement dated April 16, 2015 and an Amendment to Employment Agreement dated March
      8, 2018 (collectively the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Prior Employment Agreement</font>&#8221;); and</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Company and the Executive desire to terminate the Prior Employment Agreement and establish new terms and conditions of the Executive&#8217;s
      employment;</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the covenants and agreements hereinafter set forth, the parties hereto agree as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Duties and Responsibilities</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">A.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Executive shall serve as the Company&#8217;s Chief
        Scientific Officer and Executive Vice President of Product Development, reporting directly to the Company&#8217;s Chief Executive Officer.&#160; The Executive shall have the duties and powers at the Company that are customary for an individual holding such
        positions.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">B.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Executive agrees to use the Executive&#8217;s best
        efforts to advance the business and welfare of the Company, to render the Executive&#8217;s services under this Agreement faithfully, diligently and to the best of the Executive&#8217;s ability.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">C.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Except as may otherwise be approved in advance by the
        Nominating and Corporate Governance Committee (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Nominating and Corporate Governance Committee</font>&#8221;) of the Company&#8217;s Board of Directors
        (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Board</font>&#8221;), and except during vacation periods and reasonable periods of absence due to sickness, personal injury or other disability,
        the Executive shall devote the Executive&#8217;s full working time to the services required of him hereunder, and shall use the Executive&#8217;s best efforts, judgment and energy to improve and advance the business and interests of the Company in a manner
        consistent with the duties of the Executive&#8217;s position.&#160; The Executive may participate in charitable, civic and professional activities as long as the activities do not interfere with the performance of the Executive&#8217;s duties hereunder.&#160; The
        Executive shall not serve on the board of directors of any entity, other than an affiliate of the Company, without the approval of the Nominating and Corporate Governance Committee.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employment Period</u></font>. The Executive shall be employed by the Company under the terms of this Agreement for the period commencing on the Effective Date and ending on December 31, 2025 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Employment Period</font>&#8221;).&#160; Notwithstanding the foregoing, the Executive and the Company may terminate the Employment Period and this Agreement prior
        to December 31, 2025 in accordance with Section 7 hereof.&#160; Notwithstanding the termination of this Agreement, the provisions of Sections 7 and 8 shall survive the termination of this Agreement and shall remain in full force and effect in accordance
        with the terms thereof unless otherwise agreed to by the parties in writing.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Cash Compensation</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">A.</font>&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Annual Salary</u></font>.&#160; The Executive&#8217;s annual base salary (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Annual Salary</font>&#8221;) shall be determined by
        the Compensation Committee of the Board (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Compensation Committee</font>&#8221;), and shall be payable in accordance with the Company&#8217;s standard
        payroll schedule for its executive officers (but in no event less frequent than on a monthly basis).&#160; The Compensation Committee shall review the Executive&#8217;s Annual Salary at least annually and shall make a determination regarding any changes to
        the Annual Salary.&#160; Any changed annual salary shall thereupon be the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Annual Salary</font>&#8221; for the purposes hereof.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">B.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Bonus</u></font>.&#160; The Executive shall be eligible to participate in the Company&#8217;s cash incentive plan as adopted by the Compensation Committee at levels and upon attainment of such corporate and/or individual
        performance targets as shall be established by the Compensation Committee from time to time.&#160; The Executive shall be entitled to receive bonuses, cash or otherwise, in the discretion of the Compensation Committee, from time to time.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">C.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Applicable Withholdings</u></font>.&#160; The Company shall deduct and withhold from the compensation payable to the Executive under this Agreement any and all applicable federal, state and local income and employment
        withholding taxes and any other amounts required to be deducted or withheld by the Company under applicable statutes, regulations, ordinances or orders governing or requiring the withholding or deduction of amounts otherwise payable as compensation
        or wages to employees.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Equity Compensation</u></font>.&#160; The Executive shall be eligible to participate in any equity incentive plans of the Company in which other executive officers of the Company are eligible to participate.&#160; All options
        or other equity awards granted under the equity incentive plans will be made at the discretion of the Compensation Committee pursuant and subject to the terms and conditions of the applicable equity incentive plan.&#160; To the extent the Company grants
        any time-based equity awards (i.e., equity that vests with the passage of time) to the Executive during the Employment Period, the grant documentation for such equity awards shall provide that if a Change in Control (as defined below) is
        consummated during the Employment Period, and within six months prior to and in connection with such Change in Control or within two years following such Change in Control, the Executive&#8217;s employment is terminated (i) by the Company without Cause
        (as defined in the applicable equity plan or award agreement) or (ii) by the Executive for Good Reason (as defined in the applicable equity plan or award agreement), then all of such equity awards shall vest in full.&#160; The vesting of any
        performance-based equity awards shall be determined in accordance with the applicable equity incentive plan and grant documentation. For purposes of this Agreement, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Change in Control</font>&#8221; shall mean the consummation of any of the following transactions effecting a change in ownership or control of the Company:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">During any 24 month period, individuals who, as of
        the beginning of such period, constitute the Board (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Incumbent Directors</font>&#8221;) cease for any reason to constitute at least a majority of
        the Board, provided that any person becoming a director subsequent to the beginning of such period whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the Board (either by a
        specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director; provided, however, that no individual
        initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person
        other than the Board shall be deemed to be an Incumbent Director;</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Any &#8220;person&#8221; (as such term is defined in the Exchange
        Act and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the
        combined voting power of the Company&#8217;s then outstanding securities eligible to vote for the election of the Board (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Company Voting Securities</font>&#8221;);



        provided, however, that the event described in this paragraph (ii) shall not be deemed to be a Change in Control by virtue of any of the following acquisitions:&#160; (A) by the Company or any Subsidiary, (B) by any employee benefit plan (or related
        trust) sponsored or maintained by the Company or any Subsidiary, (C) by any underwriter temporarily holding securities pursuant to an offering of such securities, (D) pursuant to a Non-Qualifying Transaction, as defined in paragraph (iii), or (E)
        by any person of Company Voting Securities from the Company, if a majority of the Incumbent Board approves in advance the acquisition of beneficial ownership of 50% or more of Company Voting Securities by such person;</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The consummation of a merger, consolidation,
        statutory share exchange or similar form of corporate transaction involving the Company or any of its Subsidiaries that requires the approval of the Company&#8217;s stockholders, whether for such transaction or the issuance of securities in the
        transaction (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Business Combination</font>&#8221;), unless immediately following such Business Combination:&#160; (A) more than 50% of the total voting
        power of (x) the corporation resulting from such Business Combination (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Surviving Corporation</font>&#8221;), or (y) if applicable, the ultimate
        parent corporation that directly or indirectly has beneficial ownership of at least 90% of the voting securities eligible to elect directors of the Surviving Corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Parent Corporation</font>&#8221;), is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such
        Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the holders thereof
        immediately prior to the Business Combination, (B) no person (other than any employee benefit plan (or related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or
        indirectly, of 50% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the
        members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors at the time of the Board&#8217;s approval of
        the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Non-Qualifying Transaction</font>&#8221;); or</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The stockholders of the Company approve a plan of
        complete liquidation or dissolution of the Company or the consummation of a sale of all or substantially all of the Company&#8217;s assets.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Subsidiary</font>&#8221; shall mean any corporation
      (other than the Company) in an unbroken chain of corporations beginning with the Company if, at the relevant time each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined
      voting power of all classes of stock in one of the other corporations in the chain.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Expense Reimbursement</u></font>.&#160; In addition to the compensation specified in Section 3, the Executive shall be entitled to receive reimbursement from the Company for all reasonable business expenses incurred
        by the Executive in the performance of the Executive&#8217;s duties hereunder, provided that the Executive furnishes the Company with vouchers, receipts and other details of such expenses in the form reasonably required by the Company to substantiate a
        deduction for such business expenses under all applicable rules and regulations of federal and state taxing authorities.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employee Benefits</u></font>.&#160; The Executive shall, throughout the Employment Period, be eligible to participate in all of the life insurance plans, health plans, accidental death and dismemberment plans,
        short-term disability programs, retirement plans, profit sharing plans or other employee benefit plans that are available to the executive officers of the Company, for which the Executive qualifies as provided under the terms of such plans.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Termination of Employment</u></font>.&#160; During the Employment Period, the Executive&#8217;s employment with the Company may be terminated by either the Company or the Executive at any time, and for any reason.&#160; Upon such
        termination, the Executive (or, in the case of the Executive&#8217;s death, the Executive&#8217;s estate and beneficiaries) shall have no further rights to any other compensation or benefits from the Company on or after the termination of employment except as
        follows:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">A.</font>&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Executive Severance Policy</u></font>.&#160; The Executive shall be a participant in the Company&#8217;s Executive Severance Policy and shall be entitled to the rights and payments provided therein.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">B.</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Consulting Agreement</u></font>.&#160; If the Executive&#8217;s employment terminates pursuant to Section 3 or 6 of the Executive Severance Policy as in effect on the date of this Agreement, then the Company and the Executive
        agree to enter into a consulting agreement, in substantially the form attached hereto as Exhibit A (the &#8220;Consulting Agreement&#8221;).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Key-Employee Covenants</u></font>.&#160; The Executive agrees to perform the Executive&#8217;s obligations and duties and to be bound by the terms of the Key-Employee Covenants attached hereto as Exhibit B which are
        incorporated into this Section 8 by reference, and which may be modified from time to time.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Successors and Assigns</u></font>.&#160; This Agreement is personal in its nature and the Executive shall not assign or transfer the Executive&#8217;s rights under this Agreement.&#160; The provisions of this Agreement shall inure
        to the benefit of, and shall be binding on, each successor of the Company whether by merger, consolidation, transfer of all or substantially all assets, or otherwise, and the heirs and legal representatives of the Executive.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Notices</u></font>.&#160; Any notices, demands or other communications required or desired to be given by any party shall be in writing and shall be validly given to another party if served either personally or via an
        overnight delivery service such as Federal Express, postage prepaid, return receipt requested.&#160; If such notice, demand or other communication shall be served personally, service shall be conclusively deemed made at the time of such personal
        service.&#160; If such notice, demand or other communication is given by overnight delivery, such notice shall be conclusively deemed given two business days after the deposit thereof with such service, properly addressed to the party to whom such
        notice, demand or other communication is to be given as hereinafter set forth:</font></div>
    <div>&#160;</div>
    <div style="margin-left: 36pt;">
      <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="z2d962db4a0fb44bc83bbf656a547d172">

          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">To the Company:</div>
            </td>
            <td style="width: 60%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Nu Skin Enterprises, Inc.</div>
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">75 West Center Street</div>
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Provo, Utah 84601</div>
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Attn: General Counsel</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 60%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">To the Executive:</div>
            </td>
            <td style="width: 60%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">At the Executive&#8217;s last residence as provided by the Executive to the Company for payroll records.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Any party may change such party&#8217;s address for the purpose of receiving notices, demands and other communications by providing written notice to the other party in the
      manner described in this Section 10.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Governing Documents</u></font>.&#160; This Agreement, along with the documents expressly referenced in this Agreement, including the Key Employee Covenants and equity incentive plans and grant documents, constitute the
        entire agreement and understanding of the Company and the Executive with respect to the terms and conditions of the Executive&#8217;s employment with the Company and the payment of severance benefits, and supersedes all prior and contemporaneous written
        or verbal agreements and understandings (including the 2009 Employment Agreement and any other offer letter and any other existing employment agreements or arrangements, and any amendments thereto) between the Executive and the Company relating to
        such subject matter.&#160; Any and all other prior agreements, understandings or representations relating to the Executive&#8217;s employment with the Company, including the 2009 Employment Agreement, are terminated and cancelled in their entirety and are of
        no further force or effect. This Agreement may only be amended by written instrument signed by the Executive and an authorized officer of the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Governing Law</u></font>.&#160; The provisions of this Agreement will be construed and interpreted under the laws of the State of Utah, without regard to principles of conflict of laws.&#160; If any provision of this
        Agreement as applied to any party or to any circumstance should be adjudged by a court of competent jurisdiction to be void or unenforceable for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible
        by law) the application of such provision under circumstances different from those adjudicated by the court, the application of any other provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole.&#160; Should any
        provision of this Agreement become or be deemed invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent or duration of its coverage, then such provision shall be deemed amended to the extent necessary to conform to
        applicable law so as to be valid and enforceable or, if such provision cannot be so amended without materially altering the intention of the parties, then such provision will be stricken and the remainder of this Agreement shall continue in full
        force and effect.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Remedies</u></font>.&#160; The parties to this Agreement agree that:&#160; (i) the Executive&#8217;s services are unique because of the particular skill, knowledge, experience and reputation of the Executive; (ii) if the Executive
        breaches this Agreement, the damage to the Company will be substantial and difficult to ascertain, and further, that money damages will not afford the Company an adequate remedy. Consequently, if the Executive is in breach of any provision of this
        Agreement, or threatens a breach of this Agreement, the Company shall be entitled, in addition to all other rights and remedies as may be provided by law, to seek specific performance and injunctive and other equitable relief to prevent or restrain
        a breach of any provision of this Agreement notwithstanding Section 14 hereof.&#160; All rights and remedies provided pursuant to this Agreement or by law shall be cumulative, and no such right or remedy shall be exclusive of any other. All claims for
        damages for a breach of this Agreement shall be submitted to mediation and arbitration in accordance with Section 14 of this Agreement.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Dispute Resolution</u></font>.&#160; Except for the right of the Company to seek specific performance and injunctive and other equitable relief in court as set forth in Section 13 hereof, any controversy, claim or
        dispute of any type arising out of, in connection with, or in relation to the interpretation, performance or breach of this Agreement shall be resolved in accordance with this Section 14 of this Agreement, regarding resolution of disputes.&#160; This
        Agreement shall be enforced in accordance with the Federal Arbitration Act, the enforcement provisions of which are incorporated by this reference.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">A.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Mediation</u></font>.&#160; The Company and the Executive will make a good faith attempt to resolve any and all claims and disputes under this Agreement through good faith negotiations.&#160; If such claims and disputes
        cannot be settled through negotiation, the Company and the Executive agree to submit them to mediation in Salt Lake City, Utah before resorting to arbitration or any other dispute resolution procedure.&#160; The mediation of any such claim or dispute
        must be conducted in accordance with the then-current American Arbitration Association (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">AAA</font>&#8221;) procedures for the resolution of disputes by
        mediation, by a mediator (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Mediator</font>&#8221;) who has had both training and experience as a mediator of general non-competition and commercial
        matters.&#160; If the parties to this Agreement cannot agree on a Mediator, then the Mediator will be selected by AAA in accordance with AAA&#8217;s strike list method.&#160; Within 30 days after the selection of the Mediator, the Company and the Executive and
        their respective attorneys will meet with the Mediator for one mediation session of at least four hours.&#160; If the claim or dispute cannot be settled during such mediation session or mutually agreed continuation of the session, either the Company or
        the Executive may give the Mediator and the other party to the claim or dispute written notice declaring the end of the mediation process.&#160; All discussions connected with this mediation provision will be confidential and treated as compromise and
        settlement discussions.&#160; Nothing disclosed in such discussions, which is not independently discoverable, may be used for any purpose in any later proceeding.&#160; If the mediation process is ended without resolution, the Mediator&#8217;s fees will be paid in
        equal portions by the Company and the Executive.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">B.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Arbitration</u></font>.&#160; If a claim or dispute under this Agreement has not been resolved in accordance with Section 14A above, then the claim or dispute will be determined by arbitration in accordance with the
        then-current AAA comprehensive arbitration rules and procedures, except as modified herein.&#160; The arbitration will be conducted in Salt Lake City, Utah by a sole neutral arbitrator (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Arbitrator</font>&#8221;) who has had both training and experience as an arbitrator of general non-competition and commercial matters and who is, and for at least 10 years has been, a partner, a shareholder, or a
        member in a law firm.&#160; If the Company and the Executive cannot agree on an Arbitrator, then the Arbitrator will be selected by AAA in accordance with AAA&#8217;s comprehensive arbitration rules and procedures.&#160; No person who has served as a Mediator
        under the mediation provision, however, may be selected as the Arbitrator for the same claim or dispute.&#160; Reasonable discovery will be permitted and the Arbitrator may decide any issue as to discovery.&#160; The Arbitrator may decide any issue as to
        whether or as to the extent to which a dispute is subject to the dispute resolution provisions in this Section 14 and the Arbitrator may award any relief permitted by law.&#160; The Arbitrator must base the arbitration award on the provisions of this
        Section 14B and applicable law and must render the award in writing, including an explanation of the reasons for the award.&#160; Judgment upon the award may be entered by any court having jurisdiction of the matter.&#160; The statute of limitations
        applicable to the commencement of a lawsuit will apply to the commencement of an arbitration under this Section 14B.&#160; At the request of any party, the Arbitrator, attorneys, parties to the arbitration, witnesses, experts, court reporters or other
        persons present at the arbitration shall agree in writing to maintain the strict confidentiality of the arbitration proceedings.&#160; The Arbitrator&#8217;s fee will be paid in full by the Company, unless the Executive agrees in writing to pay some or all of
        the fee.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">C.</font>&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Interim Actions</u></font>.&#160; Notwithstanding the foregoing, a party may apply to a court of competent jurisdiction within the State of Utah for relief in the form of a temporary restraining order or preliminary
        injunction, pending appointment of an Arbitrator or pending determination of a claim through arbitration in accordance with this Section 14.&#160; If a dispute is submitted to arbitration hereunder during the term of this Agreement, the parties shall
        continue to perform their respective obligations hereunder, subject to any interim relief that may be ordered by the Arbitrator or by a court of competent jurisdiction pursuant to the previous sentence.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">D.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Fees</u></font>.&#160; Unless otherwise agreed, the prevailing party (if a prevailing party is determined to exist by the Arbitrator or judge) will be entitled to its costs and attorneys&#8217; fees incurred in any arbitration
        or other proceeding under this Section 14 relating to the interpretation or enforcement of this Agreement.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">E.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Acknowledgement</u></font>.&#160; EXECUTIVE HAS READ AND UNDERSTANDS THIS SECTION 14, WHICH DISCUSSES MEDIATION AND ARBITRATION.&#160; EXECUTIVE UNDERSTANDS THAT BY SIGNING THIS AGREEMENT, EXECUTIVE AGREES TO SUBMIT ANY
        CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE, BREACH OR TERMINATION THEREOF TO MEDIATION AND ARBITRATION, AND THAT THE DISPUTE RESOLUTION PROVISIONS SET FORTH
        IN THIS AGREEMENT CONSTITUTE A WAIVER OF EXECUTIVE&#8217;S RIGHT TO A JURY TRIAL.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">15.</font>&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>No Waiver</u></font>.&#160; The waiver by either party of a breach of any provision of this Agreement shall not operate as, or be construed as, a waiver of any later breach of that provision.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Taxes</u></font>.&#160; Except as otherwise provided under Section 3C, each party agrees to be responsible for its own taxes and penalties.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Counterparts</u></font>.&#160; This Agreement may be executed in more than one counterpart, each of which shall be deemed an original, but all of which together shall constitute but one and the same instrument.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">18.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Representation of the Executive; Interpretation of this Agreement</u></font>.&#160; The Executive represents and warrants to the Company that the Executive has read and understands this Agreement, has consulted with
        independent counsel of the Executive&#8217;s choice prior to agreeing to the terms of this Agreement and is entering into this Agreement, knowingly, willingly and voluntarily.&#160; The parties agree that this Agreement shall not be construed for or against
        either party in any interpretation thereof.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature Page Follows</font>]</div>
    <div>&#160;</div>
    <div></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</div>
    <div>&#160;</div>
    <div></div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z91f3f7b72f284ca0841b117e4dfac5b2">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">NU SKIN ENTERPRISES, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Ritch Wood</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Ritch Wood</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4708d69159d44a21a29b95d2e24b397c">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">EXECUTIVE</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Joseph Chang</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Joseph Y. Chang</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">[Signature Page to Employment Agreement]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT A</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSULTING AGREEMENT</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%A-%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSULTING AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Consulting Agreement (this &#8220;Agreement&#8221;) is entered into effective as of [________] (the &#8220;Effective Date&#8221;), by and between Nu Skin Enterprises, Inc., a Delaware
      corporation (the &#8220;Company&#8221;) and Joseph Y. Chang, an individual (&#8220;Consultant&#8221;). The Company and Employee are sometimes hereinafter referred to as &#8220;party&#8221; or &#8220;parties.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">RECITALS</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za55c2a5f1ac546ab8c5c1f5b8b6113cb">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">A.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Prior to the termination of Consultant&#8217;s employment, Consultant served as an Executive of the Company, pursuant to an employment agreement dated _________, 2020, as amended from time
              to time (the &#8220;Employment Agreement&#8221;).</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze943ee1be4424beb941e8734a5831e7a">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">B.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Company desires to obtain certain rights related to Consultant and to retain Consultant as an independent contractor to provide certain consulting services to the Company.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc62ca0bda7644cc98e5b089c491897bf">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">C.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">The Consultant is willing to grant such rights and provide such services pursuant to the terms and conditions set forth in this Agreement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">In consideration of the mutual promises and covenants set forth herein, and for other good and valuable consideration, the receipt, adequacy, and legal sufficiency of
      which are hereby acknowledged, the parties hereby mutually agree as follows:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd480862095234362abb2ad83fcadf445">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Term. </font>This Agreement shall commence on the Effective Date and shall continue for four
              years, unless otherwise terminated or extended (the &#8220;Consulting Term&#8221;). Either party may terminate this Agreement immediately if the other party commits a material breach of this Agreement. Upon termination of this Agreement, all obligations
              of the parties hereunder shall terminate except that (i) each party shall remain liable for any breach by such party of any covenant or obligation under this Agreement prior to the termination of this Agreement, and (ii) Consultant shall
              remain obligated and liable under the provisions of Sections 7.5, 7.8, 8, 9, 10, 12, 18 and 19, which shall survive the expiration or termination of this Agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3c5e46557fa14c148749637a499e94fb">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Engagement.</font>&#160; The Company hereby engages Consultant as an independent contractor to provide
              certain rights and consulting services as set forth in Section 3 below (the &#8220;Rights and Consulting Services&#8221;) to the Company and its affiliated entities during the Consulting Term, and Consultant hereby accepts such engagement on the terms
              and conditions set forth herein.&#160; Consultant may provide the Rights and Consulting Services as an individual in his own name, or through a business entity established for that purpose.&#160; In the event that Consultant provides the Rights and
              Consulting Services through a business entity, then both Consultant and the business entity shall be subject to all of the obligations hereunder.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4fe9012065134d9d8361327a30d71f3c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Rights and Consulting Services.</font>&#160; During the Consulting Term, Consultant shall provide the
              following Rights and Consulting Services to the Company:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za1e723b39a254dc8b549145038879c69">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Consulting services up to 10 hours per month;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdb7f768c1a8743b4974b694c6c0b73bb">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Service as a member of the Company&#8217;s Scientific Advisory Board;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd84380cd568f4f2386e57b27693875d8">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Appearances and speaking engagements up to 10 days per year; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-1</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z957c936be74f4dcf9acc640b437375c7">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">d.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Full rights and authorization to use Consultant&#8217;s name and likeness for the Company&#8217;s marketing and other purposes.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb924620149644d4fa23436059a08468e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Consulting Fees</font>. During the Consulting Term, the Company agrees to pay Consultant an annual
              consulting fee of $287,500 less any severance payments pursuant to Section 3 or 6 of the Executive Severance Policy (other than Accrued Rights, as defined in such policy) paid to Consultant during the year (the &#8220;Consulting Fee&#8221;). The
              Consulting Fee shall be paid in equal monthly installments.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc70399f8dfd40ce84aefe2423543c60">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Reimbursement of Expenses</font>. The Company agrees to reimburse Consultant for, or pay directly,
              reasonable expenses Consultant incurs in connection with the services provided hereunder, provided such expenses have been approved in advance by the Company and Consultant submits adequate documentation for such expenses including the
              purpose of the expense and the names of all persons who participated in any meetings or meals covered by such expenses.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z154ef650cc8046cea737e3a481deb7d8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Independent Contractor</font>. Consultant acknowledges that he is an independent contractor and the
              Company shall not be responsible to compensate Consultant for, or make any withholdings such as, FICA, worker&#8217;s compensation, unemployment taxes, or any other similar taxes or fees associated with employment.&#160; Under no circumstances is
              Consultant to be considered an employee of the Company.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf787f63dc0c41cd8e935c26a91d6c62">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Restrictive Covenants.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Definitions</font>.&#160; For purposes of this Agreement, the following defined terms shall have the meaning indicated:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;Competitive Business&#8221; shall mean
        Direct Selling.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;Competing Entity&#8221; shall mean any
        entity or person that is engaged, directly or indirectly, in a Competitive Business.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;Direct Selling&#8221; means (i) the
        multi-level marketing channel through which products and services are marketed directly to consumers through a sales force of independent contractors (including, without limitation, through person to person contact, via the telephone or through the
        Internet) who receive rewards or commissions based upon a compensation plan which contemplates a genealogical sales force of multiple levels, with such commissions paid for by (A) sales of products and services by such contractor, and/or (B) sales
        of products and services by other independent contractors in such contractor&#8217;s genealogical downline, and (ii)&#160; a home-based business opportunity focused on selling products directly to the consumers.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;Territory&#8221; shall mean those
        countries where the Company, or any of its affiliates, engages in business or sells products or plans to conduct business.&#160; This definition is intended to reflect the Consultant&#8217;s knowledge about the operations and activities of the Company as a
        whole.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Non-Competition</font>. Consultant shall not in any way, directly or indirectly, at any time during the Consulting Term, within the Territory: (i) engage in any Competitive Business; (ii)
        undertake to plan or organize any Competing Entity; (iii) become associated or connected in any way with, participate in, be employed by, render services to, or consult with, any Competing Entity (nor shall Consultant discuss the possibility of
        employment or other relationship with any Competing Entity); or (iv) own any direct or indirect interest in any other Competing Entity; provided, however, this limitation shall not be interpreted as prohibiting Consultant from investing in a
        Competing Entity that is a public company so long as such investment does not exceed 1% of the outstanding securities of such public company and Consultant discloses in writing to the Company (a) the name of the public company and the number of
        shares which he owns, and (b) any material change in Consultant&#8217;s ownership. This Section 7.2 shall not restrict the right of the Employee to practice law in violation of any applicable rules of professional conduct.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Non-Solicitation</font>. Consultant shall not in any way, directly or indirectly, at any time during the Consulting Term solicit any employee, independent contractor, consultant or other person
        or entity in the employment or service of the Company or any of its respective subsidiaries or affiliates (each of the preceding, a &#8220;Group Company&#8221;), at the time of such solicitation, in any case to (i) terminate such employment or service, and/or
        (ii) accept employment, or enter into any consulting or other service arrangement, with any person or entity other than a Group Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Non-Endorsement</font>. Consultant shall not in any way, directly or indirectly, at any time during the Consulting Term endorse any Competitive Business or competing product, promote or speak
        on behalf of any Competitive Business or competing product, or allow Consultant&#8217;s name or likeness to be used in any way to promote any Competitive Business or competing product.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Non-Disparagement</font>. Consultant shall not in any way, directly or indirectly at any time during or after the Consulting Term, disparage the Company or the Company&#8217;s products or sales
        force.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Acknowledgement</font>. Consultant acknowledges that the Rights and Consulting Services are critical and vital to the on-going success of the Company&#8217;s operation in each product category and in
        each geographic location in which the Company operates.&#160; In addition, the Consultant acknowledges that Consultant&#8217;s experience with, and knowledge of the Company&#8217;s operations as a whole constitute skills and knowledge which are special, unique and
        extraordinary with respect to Consultant&#8217;s service to the Company.&#160; Therefore, Consultant acknowledges that the non-competition, non-solicitation, non-endorsement and non-disparagement covenants hereunder are fair, reasonable and necessary to
        protect the legitimate business interests of the Company.&#160; These covenants, and each of them, should be construed to apply to the fullest extent possible by applicable laws. Consultant has carefully read this Agreement, has consulted with
        independent legal counsel to the extent Consultant deems appropriate, and has given careful consideration to the restraints imposed by this Agreement. Consultant acknowledges that the terms of this Agreement are enforceable regardless of the manner
        in which this Agreement is terminated.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">7.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Remedies</font>. Consultant acknowledges: (a) that compliance with the restrictive covenants contained in this Section 7 are necessary to protect the business and goodwill of the Company or its
        affiliates and (b) that a breach of the restrictive covenants contained in this Section 7 may result in irreparable and continuing damage to the Company or its affiliates, for which money damages may not provide adequate relief.&#160; Consequently,
        Consultant agrees that, in the event that Consultant breaches or threatens to breach these restrictive covenants, the Company or its affiliates shall be entitled to (1) a preliminary or permanent injunction, without bond, to prevent the
        continuation of harm and (2) money damages insofar as they can be determined with respect to a material breach.&#160; Nothing in this Agreement shall be construed to prohibit the Company or its affiliates from also pursuing any other remedy, the parties
        having agreed that all remedies are cumulative.</font></div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf10f7993bf2b4785918ba97f3a9768f6">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Work Product</font>. The Company shall have the sole proprietary interest in the work product
              produced by Consultant pursuant to the Rights and Consulting Services provided under this Agreement (the &#8220;Work Product&#8221;) in accordance with applicable laws.&#160; Further, Consultant expressly assigns to the Company or its designee all rights,
              title and interest in and to all copyrights, patents, trade secrets, improvements, inventions, sketches, models and all documents related thereto, innovations, business plans, designs and any other Work Product developed by Consultant in
              connection with the Rights and Consulting Services in accordance with applicable laws. Consultant further agrees to promptly disclose any and all Work Product to Company.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z27f7cd06b3c64cd998afe712fe26f2d5">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Confidential Information</font>. Consultant acknowledges that during the Consulting Term he may
              develop, learn and be exposed to information about the Company and its business, including but not limited to formulas, business plan and processes, financial data, vendor lists, product and marketing plans, sales force lists and other trade
              secrets which information is secret and confidential (&#8220;Confidential Information&#8221;). Consultant agrees that Consultant will not at any time during or after the Consulting Term, without the express written consent of the Company, disclose, copy,
              retain, remove from the Company&#8217;s premises or make any use of such Confidential Information except as may be required in the course of the Rights and Consulting Services.&#160; At the end of the Consulting Term, or at the earlier request of the
              Company, Consultant shall promptly return to the Company all Confidential Information. Consultant expressly assigns to the Company or its designee all rights, title and interest in all Confidential Information. Notwithstanding the foregoing,
              for purposes of this Agreement, Confidential Information does not include any information which is currently in the public domain or which hereafter becomes public knowledge in a way that does not involve a breach of an obligation of
              confidentiality.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z90b1d0d1432040009e49c49e258fe94c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Cooperation</font>.&#160; Consultant agrees that, upon the Company&#8217;s reasonable request, Consultant in
              good faith and using diligent efforts shall cooperate and assist the Company in any dispute, controversy or litigation in which the Company may be involved including, without limitation, Consultant&#8217;s participation in any court or arbitration
              proceedings, the giving of testimony, the signing of affidavits or such other personal cooperation as counsel for the Company may reasonably request.&#160; Such cooperation shall not be unreasonably burdensome without reasonable compensation.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z59ccf496bd684bea84985a6959bb67e2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Compliance with Laws</font>.&#160; Consultant agrees to comply with all applicable laws in the
              performance of his obligations under this Agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z75cb3047ffb3470b996d7f9743acdee1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Indemnification</font>. Consultant shall indemnify and hold the Company and its affiliates, and
              each of their respective officers, directors, employees and agents, harmless from any and all liabilities, damages, judgments, or expenses, including reasonable attorney&#8217;s fees, resulting or arising from, directly or indirectly, any acts or
              omissions by Consultant. Consultant further agrees to indemnify and hold each of the Company and its affiliates, and each of their officers, directors, employees and agents, harmless from any withholding tax, unemployment payments, fees,
              penalties, expenses, assessments or other liabilities that the Company or its affiliates may incur as a result of any determination or claim that Consultant is an employee of the Company.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3e54ffb77fb148af927129e2c0211749">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Assignment</font>. This Agreement is for the unique personal services of Consultant and is not
              assignable or delegable in whole or in part by Consultant or the Company without the prior written consent of the other party; provided the Company may assign its rights and obligations hereunder to an Affiliate of the Company or in
              connection with the sale of its business, and provided Consultant may perform his personal services through a business entity established for those purposes.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbd4e15c7180b45c09a2e088fe88b422a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Waiver and Modification</font>.&#160; Any waiver, change, modification, extension, discharge, or
              amendment of any provision of this Agreement shall be effective only if in writing in a document that specifically refers to this Agreement and the party against whom enforcement of such waiver, change, modification, extension, discharge, or
              amendment is sought signs such document.&#160; The waiver by either party of a breach of any provision of this Agreement by the other party shall not operate or be construed as a waiver of any other provision hereof or any subsequent breach of the
              same provision.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4bf97cbd57714061bd67dc5bbf4f8094">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Severability, Interpretation</font>.&#160; If any provision of this Agreement is found to be
              unenforceable by a court of competent jurisdiction, the remaining provisions hereof shall nevertheless remain in full force and effect.&#160; Notwithstanding any rule or maxim of construction to the contrary, any ambiguity or uncertainty in this
              Agreement shall not be construed against either of the parties based upon authorship of any of the provisions hereof.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f2ab72be7c24a8c8fd371a1a81d37f1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Reformation</font>. The Company intends to restrict the activities of the Consultant only to the
              extent necessary for the protection of the legitimate business interests of the Company and its affiliates.&#160; It is the intention and agreement of the parties that all of the terms and conditions hereof be enforced to the fullest extent
              permitted by law.&#160; If the provisions of this Agreement should ever be deemed or adjudged by a court of competent jurisdiction to exceed the time or geographical limitations permitted by applicable law, then such provisions shall nevertheless
              be valid and enforceable to the extent necessary for such protection as determined by such court, and such provisions will be reformed to the maximum time or geographic limitations as determined by such court.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze0e4ae246f3146a088baf4af0bc48e81">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Notices</font>.&#160; Any notice required or permitted hereunder to be given by either party shall be in
              writing and shall be delivered personally or sent by certified or registered mail, postage prepaid, or by private overnight courier, or by facsimile (with a conforming copy sent by overnight mail) to the address or fax number set forth below
              or to such other address as either party may designate from time to time according to the terms of this Section 17:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>
      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;" id="zcd7d972fb2864bb6ae1489729b0191b8">

            <tr>
              <td style="width: 25%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">If to Consultant:</font></td>
              <td style="width: 25%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Joseph Chang</font></td>
              <td style="width: 30%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 80%;">

            <tr>
              <td style="width: 25%;">
                <div>If to the Company:</div>
              </td>
              <td style="width: 25%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">Nu Skin Enterprises, Inc.</div>
              </td>
              <td style="width: 30%;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;" rowspan="1">&#160;</td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
              <td style="width: 30%; padding-bottom: 2px;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;" rowspan="1">&#160;</td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
              <td style="width: 30%; padding-bottom: 2px;" rowspan="1">&#160;</td>
            </tr>

        </table>
      </div>
      <br>
    </div>
    <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A notice delivered personally shall be effective upon receipt.&#160; A notice sent by facsimile shall be effective the date delivered, provided
      confirmation of delivery is obtained and a copy is delivered by overnight mail, 24 hours after the dispatch thereof.&#160; A notice delivered by private overnight courier shall be effective on the day delivered or if delivered by mail, the third day after
      the day of mailing.&#160; Either party may change its address for purposes of this Section 17 by providing the other party notice as required herein.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43acfe83504e433fb9cf891565c0c0c4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">18.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Attorneys&#8217; Fees</font>.&#160; In the event of any action at law or in equity to enforce or interpret the
              terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys&#8217; fees and court costs in addition to any other relief to which such party may be entitled.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54a004b3cfcd454fa500452d8bcab7e9">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">19.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Governing Law, Jurisdiction and Venue</font>.&#160; The validity of this Agreement and the
              interpretation and performance of all of its terms shall be governed by the substantive and procedural laws of the State of Utah.&#160; Each party expressly submits and consents to exclusive personal jurisdiction and venue in the courts of Utah
              County, State of Utah or in any Federal District Court in Utah.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0213397e21414499b2601aea8601ac19">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">20.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Entire Agreement</font>.&#160; This Consulting Agreement, together with the Separation and Release
              Agreement entered into pursuant to the Company&#8217;s Executive Severance Policy, the Employment Agreement and the Key-Employee Covenants Agreement as amended by the Employment Agreement, and the agreements related to the Company&#8217;s deferred
              compensation plan, the Company&#8217;s 401(k) plan, and Consultant&#8217;s stock option agreements (the &#8220;Sole Agreements&#8221;), constitute the entire and sole agreements between Consultant and the Company and its affiliates.&#160; No other promises or agreements
              have been made to Consultant or the Company other than those contained in the Sole Agreements. Consultant and the Company acknowledge that they have read this Consulting Agreement carefully, fully understand the meaning of the terms of this
              Consulting Agreement, and are signing this Consulting Agreement knowingly and voluntarily.&#160; This Consulting Agreement may not be modified except by an instrument in writing signed by all of the parties hereto.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">[Signature page follows]</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-6</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first set forth above.</div>
    <div>&#160;</div>
    <div></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z99bf4571b2c14371afcef219ce126a2c">

        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">NU SKIN ENTERPRISES, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>
        </tr>
        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Its:</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbfa8f69388ef40ad888e539df2031290">

        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">EMPLOYEE</div>
          </td>
        </tr>
        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 51.93%; vertical-align: top;">&#160;</td>
          <td style="width: 48.07%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Joseph Y. Chang</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">A-7</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT B</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">KEY EMPLOYEE COVENANTS</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%B-%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">KEY EMPLOYEE COVENANTS AGREEMENT</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zc8e05024474b4b3c90dbd8a33715a89e">

          <tr>
            <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman';">Joseph Y. Chang<br>
              </font></td>
            <td style="width: 80%; padding-bottom: 2px;">&#8220;Employee&#8221;</td>
          </tr>
          <tr>
            <td style="width: 20%;">(PRINT NAME)</td>
            <td style="width: 80%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Nu Skin Enterprises, Inc. and its affiliated companies (&#8220;Company&#8221;) operate in the highly competitive direct selling marketplace competing for product market share as
      well as recruitment and retention of independent distributors.&#160; The success of Company depends on maintaining a competitive edge in this industry through the introduction of innovative products and attracting and retaining distributors. Accordingly,
      as a condition of and in consideration of employment or continued employment with Company and participation in the Executive Severance Policy maintained by Company, the parties hereby acknowledge and agree as follows.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9661341986334d178adfe9dbff2e3505">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Conflict of Interest</u></font>:&#160; During employment with Company, Employee shall not have any
              personal interest that is incompatible with the loyalty and responsibility owed to the Company.&#160; Employee must discharge his/her responsibility solely on the basis of what is in the best interest of Company and independent of personal
              considerations or relationships. Employee shall maintain impartial relationships with vendors, suppliers and distributors. Should Employee have any questions regarding this matter, Employee should consult with his/her director or supervisor.&#160;
              If any conflict of interest or potential conflict of interest arises, the Employee must notify his director or supervisor and seek an appropriate waiver or resolution of such conflict of interest. Although it is difficult to identify every
              activity that might give rise to a conflict of interest, and not by way of making an all-inclusive list, the following provisions apply to common areas for potential conflicts of interests:</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a4b0d94abcf48ffb462a89536301d8f">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.1</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Related Party Transactions.</font>&#160; Employees should not have a direct or indirect ownership or
              financial interest in vendors of Company nor any company doing or seeking to do business with Company. Employees should also not have a financial or other interest in any transaction involving the Company.&#160; In the event such a conflict
              arises, the Employee must notify his/her director or supervisor and the Company may not do business with such vendor or enter into any such transaction unless it has been approved in accordance with the Company&#8217;s policy with respect to
              related party transactions.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7945208b6521477abeed620883a2cd60">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.2</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Other Employment.</font>&#160; Employee shall not perform services of any kind for any entity doing or
              seeking to do business with Company. As to employment with or service to another company, Employee shall not provide service to any company that competes with the Company, and shall not allow any such activity to detract from his/her job
              performance, use Company&#8217;s time, resources or personnel, or require such long hours to affect his/her physical or mental effectiveness.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d0f2045c2ab4bc2b5142a3ab191a695">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">1.3</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Distributorships.</font>&#160; While employed by Company and for a period of three (3) months after
              termination of an employment relationship with Company, Employee shall not directly or indirectly own any interest in a Company distributorship or similar account.&#160; Additionally, during the course of employment, neither the Employee&#8217;s spouse,
              nor any member of the Employee&#8217;s household shall own any interest in, or otherwise be associated with, a Company distributorship without the prior written consent of the Company. Employee&#8217;s spouse, or significant other living in the same
              household, will not, without the prior written consent of the Company, own any interest in, or otherwise be affiliated with, another direct sales distributorship or be employed by another direct sales or multilevel marketing company.&#160; Any
              pre-existing ownership interests or employment covered in this paragraph must be disclosed to the Company at the time of the execution of this Agreement.&#160; Employee shall disclose to his/her immediate director or supervisor any and all areas
              posing a potential or actual conflict of interest.&#160; Said disclosure shall be made as promptly as possible after such conflict arises.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-1</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43ce085aa8734e1680a3bae1dcf0b4e1">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Work Product</u></font>:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze0cf8903ee47411ba6370d8823699b15">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">2.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Company shall have the sole proprietary interest in the work product of Employee created&#160; during his/her employment with Company (&#8220;Work Product&#8221;), and Employee expressly assigns to
              Company or its designee all rights, title and interest in and to all copyrights, patents, trade secrets, improvements, inventions, sketches, models and all documents related thereto, manufacturing processes and innovations, special
              calibration techniques, software, service code, systems designs and any other Work Product developed by Employee, either solely or jointly with others, where said Work Product relates to any business activity or research and development
              activity in which Company is involved or plans to be involved at the time of or prior to Employee&#8217;s creating such Work Product, or where such Work Product is developed with the use of Company&#8217;s time, material, or facilities; and Employee
              further agrees to disclose any and all such Work Product to Company without delay.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z04eb289deb0d4d3b97c1f2b5f78017c3">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">2.2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Employee will promptly disclose to the Company all Work Product, whether or not patentable or registrable under patent, copyright or similar statutes, made or conceived or reduced to
              practice or learned by Employee, either alone or jointly with others, during the period of his/her employment that (i) at the time of conception or reduction to practice are related to the actual or demonstrably anticipated business of the
              Company, (ii) result from tasks performed by Employee for the Company, or (iii) are developed on any amount of the Company&#8217;s time or result from the use of premises or property (including computer systems and engineering facilities) owned,
              leased, or contracted for by the Company (collectively, &#8220;Inventions&#8221;).</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf9fb8a461784de4ac6e9b87c48d60db">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Non-Disclosure and Assignment</u></font>:</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z448d0d17b1114e5ba53508c1b319036a">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.1</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Employee acknowledges that during the term of employment with Company he/she may develop, learn and be exposed to information about Company and its business, including but not
              limited to formulas, business plans, financial data, vendor lists, product and marketing plans, distributor lists, and other trade secrets which information is secret, confidential and vital to the continued success of Company (&#8220;Confidential
              Information&#8221;).&#160; All Confidential Information and/or Inventions, as well as all intellectual property rights therein, are and shall be the sole property of the Company.&#160; Employee hereby assigns and agrees to assign to the Company any rights he
              or she may have or acquire in such Confidential Information and/or Inventions.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05fdbe1943924c2c81743459c5917775">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.2</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">During and after Employee&#8217;s employment, Employee shall hold the Confidential Information and/or Inventions in confidence and shall protect them with utmost care. Employee shall not
              disclose, copy, remove from the Company&#8217;s premises, or permit any person to disclose or copy any of the Confidential Information and/or Inventions, and Employee shall not use any of the Confidential Information and/or Inventions, except as
              necessary to perform his/her duties as an employee of Company.&#160; In the event that Employee has or has had access to any confidential information belonging to any third party, including but not limited to any of Employee&#8217;s previous employers,
              Employee shall hold all such confidential information in confidence and shall comply with the terms of any and all agreements between Employee or Company and the third party with respect to such confidential information. Upon hire, Employee
              shall disclose to Company the existence of agreements Employee has with prior employers.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbbfa7be0d6824902b13f920b5fde5f9e">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.3</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">This Agreement will not be interpreted to prevent the use or disclosure of information that (i) is required by law to be disclosed, but only to the extent that such disclosure is
              legally required, (ii) becomes a part of the public knowledge other than by a breach of an obligation of confidentiality, or (iii) is rightfully received from a third party not obligated to hold such information confidential.&#160; The Defend
              Trade Secrets Act provides immunity to individuals under any federal or state trade secret law for the disclosure of a trade secret that is made: (i) in confidence to a federal, state, or local government official, either directly or
              indirectly, or to an attorney for the sole purpose of reporting or investigating a suspected violation of law; or (ii) in a complaint or other document filed in a lawsuit or other proceedings, if such filing is made under seal.&#160; If an
              individual files a lawsuit against his or her employer alleging retaliation for reporting a suspected violation of law, the individual may disclose the trade secret to his or her attorney.&#160; The individual may also use the trade secret
              information in the court proceedings, provided that he or she files any documents containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc600e37217394d1f923633595bfe4bc5">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.4</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Upon Company&#8217;s request, and in any event upon termination of Employee&#8217;s employment for any reason, Employee shall promptly return to Company all materials in his/her possession or
              control that represent, contain or reasonably could contain Confidential Information and/or Inventions, including but not limited to passwords, documents, drawings, diagrams, flow charts, computer programs, memoranda, notes, and every other
              medium, and all copies thereof.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ecf90bdcb5d445190a826cbf3ce2c82">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">3.5</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Subject to Paragraph 17 below, during and after Employee&#8217;s employment, regardless of the circumstances of Employee&#8217;s termination, Employee shall not communicate to, or use for
              his/her benefit, or for the benefit of any person, firm, or other entity, without the prior approval of the Company, any Confidential Information or information about Inventions; provided, however, that Employee may communicate such
              information as required pursuant to law or as necessary or appropriate in connection with any suit or action, or any potential suit or action, brought by Employee against the Company in connection with his/her employment relationship with the
              Company. Except as outlined in Paragraph 17 below, Employee must advise Company prior to disclosure of Confidential Information to be communicated pursuant to law or in connection with a suit or action as described above so that the Company
              may obtain a protective order as necessary to protect its confidentiality interests. Employee will return to Company all Company-owned materials including, without limitation, computer and office equipment, supplies and internal Company
              manuals, customer lists and information, passwords, and marketing materials.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z39cb970334fb4a3b8eb8d8b8944abdec">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Future Inventions</u></font>:&#160; Employee recognizes that Inventions relating to his/her activities
              while working for Company and conceived or made by Employee, whether alone or with others, within one year after termination of Employee&#8217;s employment may have been conceived in significant part while employed by Company.&#160; Accordingly,
              Employee agrees that such Inventions shall be presumed to have been conceived during Employee&#8217;s employment with Company and are to be, and hereby are, assigned to Company unless and until Employee has established the contrary.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0954268777084c8bae3e0e18397330e4">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Cooperation</u></font>:&#160; Employee shall assist Company in every way deemed necessary or desirable
              by the Company (but at the Company&#8217;s expense) to obtain and enforce patents, copyrights, trademarks and other rights and protections relating to any Confidential Information and Inventions in any and all countries, and to that end Employee
              will execute all documents for use in obtaining and enforcing such patents, copyrights, trademarks and other rights and protections as Company may desire, together with any assignments thereof to Company or persons designated by it.&#160; If
              Company is unable for any reason to secure Employee&#8217;s signature to any document required to apply for or execute any patent, copyright, mask work or other applications with respect to any Inventions (including improvements, renewals,
              extensions, continuations, divisions or continuations in part thereof), Employee hereby irrevocably designates Company and its duly authorized officers and agents as Employee&#8217;s agents and attorneys-in-fact for and on Employee&#8217;s behalf to
              execute and file any such application and to do all other lawfully permitted acts to further the prosecution and issuance of patents, copyrights, mask works or other rights thereon with the same legal force and effect as if executed by
              Employee.&#160; Employee&#8217;s duty to assist Company extends to enforcement of patents, copyrights, trademarks, and other rights and protections described above, of which were executed and signed on Employee&#8217;s behalf pursuant to Employee&#8217;s
              designation of Company for signatory authority.&#160; Employee&#8217;s obligation to assist Company shall continue beyond the termination of his/her employment, but Company shall compensate him/her at a reasonable rate after his/her termination for time
              actually spent by Employee at Company&#8217;s request on such assistance.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0b502bce91924e0682002e8cee9a5574">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Ethical Standards</u></font>:&#160; Employee agrees to maintain the highest ethical and legal
              standards in his/her conduct, to be scrupulously honest and straight-forward in all of his/her dealings and to avoid all situations which might project the appearance of being unethical or illegal.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae3b4a37ee724ae0954b97a7adfde352">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Product Resale</u></font>:&#160; As an employee of Company, Employee may receive Company products and
              materials either at no charge or at a discount as specified from time to time by Company in its sole discretion.&#160; Employee agrees that the products received shall be used strictly in accordance with the policies of the Company regarding
              products received by employees from the Company and shall not be sold, distributed or transferred in any manner that would violate such policies, as they may be amended from time to time.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z83ca6ab39de94e11a6ab935fbd84310f">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Gratuities</u></font>:&#160; Employee shall neither seek nor retain gifts, gratuities, entertainment
              or other forms of compensation, benefit, or persuasion from suppliers, distributors, vendors or their representatives without the consent of a Company Vice President with the exception of meals provided in the ordinary course of business on
              an infrequent basis.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf445df2efc934647b80b56256ba76fef">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Non-Solicitation</u></font>:&#160; Employee shall not in any way, directly or indirectly, at any time
              during employment or within two (2) years after either a voluntary or involuntary employment termination: (a) solicit, divert, take away, or unreasonably interfere with Company&#8217;s distributors; (b) in any manner solicit, divert, take away, or
              interfere unreasonably with Company&#8217;s employees or vendors; or (c) assist any other person(s) in any manner&#160; in an attempt to do any of the foregoing.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2af10c924e4048d4916b812f435821d4">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Non-Disparagement</u></font>:&#160; Subject to Paragraph 17 below, employee shall not in any way,
              directly or indirectly at any time during employment or after either voluntary or involuntary employment termination, disparage Company, Company products or Company Distributors.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3b9330ccda1246228e6c5029529ddddc">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Non-Endorsement</u></font>:&#160; Employee shall not in any way, directly or indirectly, at any time
              during employment or within one (1) year after either a voluntary or involuntary employment termination endorse any sales compensation plan of another company or product that competes with products of Company, promote or speak on behalf of
              any company whose products compete with those of Company, or allow Employee&#8217;s name or likeness to be used in any way to promote any company or product that competes with Company or any products of Company.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z74bec3e2b56f40159c307c3b3980cf6e">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Non-Competition</u></font>:&#160; Because of the Company&#8217;s legitimate business interest, in exchange
              for the benefits of continued employment by Company and participation in the Executive Severance Policy maintained by Company, Employee shall not accept employment with, contribute Employee&#8217;s knowledge, engage in or participate, directly or
              indirectly, individually or as an officer, director, employee, shareholder, consultant, partner, joint venturer, agent, equity owner, distributor or in any other capacity whatsoever, with any entity engaged in the same or similar business as
              the Company, including those engaged in the business of LED light source growing, or direct selling that competes with the business of Company whether for market share of products or for independent distributors in a territory in which
              Company is doing business; provided, however, Employee may own publicly-traded securities of a company&#8217;s whose securities are publicly traded on either the NYSE, American or NASDAQ stock exchanges if the Employee&#8217;s ownership interest is less
              than 1% of the total outstanding securities of such company.&#160; The Employee shall not engage in activities that may require or inevitably require disclosure of trade secrets, proprietary information, or Confidential Information.&#160; The
              restrictions set forth in this paragraph shall remain in effect during the Employee&#8217;s employment with Company and during a period of one (1) year following the Employee&#8217;s termination<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>of<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>employment.&#160; Within fifteen (15) days of termination of Employee&#8217;s employment, Company shall notify Employee
              whether it elects to enforce the Employee&#8217;s obligation set forth in this paragraph. Notwithstanding the foregoing, in the event Company decides, in its sole discretion, to enforce Employee&#8217;s non-competition obligation(s) with regard to an
              Employee whose employment ended as a result of the Employee&#8217;s voluntary termination of employment without Good Reason (as defined in the Executive Severance Policy maintained by Company), Company may elect, in its sole discretion, to pay
              Employee a sum of up to seventy-five percent of the Employee&#8217;s annual base salary at termination of employment, less applicable withholding taxes, for the one year period following the termination of employment during which the restrictive
              covenants in this paragraph remain in effect. Unless other arrangements are made at Company&#8217;s sole discretion, such payment may be made in equal periodic installments in accordance with Company&#8217;s regular payroll practices until all payments
              are completed. Such ongoing payments shall be contingent upon Employee&#8217;s ongoing compliance with his/her continuing obligations under this Agreement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed17050cd40746dd96f3503dd21f88b5">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Acknowledgement</u></font>:&#160; Employee acknowledges that his/her position and work activities with
              the Company are &#8220;key&#8221; and vital to the on-going success of Company&#8217;s operation in each product category and in each geographic location in which Company operates. In addition, Employee acknowledges that his/her employment or involvement with
              any other entity or company engaged in the business of LED light source growing, or direct selling or multilevel marketing would create the impression that Employee has left Company for a &#8220;better opportunity,&#8221; which could damage Company by
              this perception in the minds of Company&#8217;s employees, independent distributors, or other persons. Therefore, Employee acknowledges that his/her confidentiality, non-solicitation, non-disparagement, non-endorsement and non-competition covenants
              are fair and reasonable and should be construed to apply to the fullest extent possible by applicable laws.&#160; Employee has carefully read this Agreement, has consulted with independent legal counsel to the extent Employee deems appropriate,
              and has given careful consideration to the restraints imposed by the Agreement. Employee acknowledges that the terms of this Agreement are enforceable regardless of the manner in which Employee&#8217;s employment is terminated, whether voluntary or
              involuntary. In the event that Employee is to be employed as an attorney for a competitive business, Company and Employee acknowledge that paragraph 12 is not intended to restrict the right of the Employee to practice law in violation of any
              applicable rules of professional conduct.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaaa2e05120404756a36db70c80b71301">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Return of Equipment and Information upon Termination</u></font>:&#160; Upon termination of employment,
              Employee shall return to Company all assets and equipment of Company along with any Confidential Information and Work Product including any distributor and vendor contact information and notes or summaries of all of the above.&#160; Employee shall
              not retain any copies of the returned items.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec4f97de94924841a25b60554d5edc77">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Remedies</u></font>:&#160; Employee acknowledges: (a) that compliance with the restrictive covenants
              contained in this Agreement are necessary to protect the business and goodwill of Company and (b) that a breach will result in irreparable and continuing damage to Company, for which money damages may not provide adequate relief.
              Consequently, Employee agrees that, in the event that he/she breaches or threatens to breach these restrictive covenants, Company shall be entitled to both: (1) a preliminary or permanent injunction to prevent the continuation of harm and (2)
              money damages insofar as they can be determined. Nothing in this Agreement shall be construed to prohibit Company from also pursuing any other remedy, the parties having agreed that all remedies are cumulative.&#160; It is further recognized and
              agreed that the covenants set forth herein are for the purpose of restricting Employee&#8217;s activities to the extent necessary for the protection of the legitimate business interests of Company and that Employee agrees that said covenants do not
              and will not preclude him/her from engaging in activities sufficient for the purposes of earning a living.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3727f545701d49c4ab1f7cafa210f1cd">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Attorney&#8217;s Fees</u></font>:&#160; If any party to this Agreement breaches any of the terms of this
              Agreement, then that party shall pay to the non-defaulting party all of the non-defaulting party&#8217;s costs and expenses, including reasonable attorney&#8217;s fees, incurred by that party in enforcing the terms of this Agreement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z248da98b87844706879aa6f4524ed9fe">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Protected Activity. </u></font>Nothing in this document is intended, or should be interpreted,
              to restrict, impede, or otherwise limit the rights of all employees, including Key Employees, to report possible violations of law or regulation to any governmental agency or entity tasked with enforcing such laws and regulations, including
              but not limited to the United States Department of Justice, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Department of Labor, Congress, and any agency Inspector General, or participate in an
              investigation by any such administrative agencies; nor is this document intended to limit employees&#8217; rights to discuss among themselves or others wages, benefits, and other terms and conditions of employment or workplace matters of mutual
              concern, as protected by the National Labor Relations Act.&#160; Employee is not required to notify the Company of his or her intention to file such a report or participate in such an investigation prior to contacting the agency.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z65932fab20f8428c8291faf274f03a9b">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">18.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Court&#8217;s Right to Modify Restriction</u></font>:&#160; The parties have attempted to limit the
              Employee&#8217;s right to compete only to the extent necessary to protect Company from unfair competition. The parties recognize, however, that reasonable people may differ in making such a determination. Consequently, the parties agree that, if
              the scope or enforceability of the restrictive covenants contained in this Agreement is in any way disputed at any time, a court or other trier of fact may modify and enforce the covenants to the extent that it believes to be reasonable under
              the circumstances existing at that time.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8ead19dfc054ca3ba13344d804111d3">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">19.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Severability</u></font>:&#160; If any provision, paragraph, or subparagraph of this Agreement is
              adjudged by any court or administrative agency to be void or unenforceable in whole or in part, this adjudication shall not affect the validity of the remainder of the Agreement, including any other provision, paragraph, or subparagraph. Each
              provision, paragraph, and subparagraph of this Agreement is severable from every other provision, paragraph, and subparagraph and constitutes a separate and distinct covenant.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9fbccabcece2464daf5699d4d76e51c5">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">20.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Governing Law and Forum</u></font>:&#160; This Agreement shall be governed and enforced in accordance
              with the laws of the State of Utah, and any litigation between the parties relating to this Agreement shall be conducted in the courts of Utah County or Salt Lake City where necessary for federal court matters.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79d725e0f40340d99839791e74c8b934">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">21.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employment At Will</u></font>:&#160; Employee understands that employment with Company is at-will,
              meaning that employment with Company is completely voluntary and for an indefinite term and that either Employee or Company is free to terminate the employment relationship at any time, with or without cause or advance notice, provided that
              termination is not done for an unlawful or discriminatory purpose.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb92406bfea5c485592408fd36b179024">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">22.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employment Subject to Company&#8217;s Policies and Procedures</u></font>:&#160; The Parties acknowledge and
              agree that Company has established, and may establish, various workplace policies and procedures, which the Company may modify in its sole discretion from time to time.&#160; Employee acknowledges such policies and procedures, and agrees to abide
              by such policies and procedures as they may be implemented or modified from time to time.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z86c1f0bda50d4c3c97a26603ec630e6e">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">23.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Entire Agreement</u></font>:&#160; Company and Employee understand and agree that this Agreement and
              the Employment Agreement by and between Company and Employee shall constitute the entire agreement between them regarding the subject matter contained herein, and that all prior understandings or agreements regarding these matters are hereby
              superseded and replaced, including, without limitation, the Key-Employee Covenants Agreement previously signed by the parties.&#160; Any amendment to or modification of this Agreement must be in writing signed by the parties hereto and stating the
              intent of the parties to amend or modify this Agreement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf2784768acd44a278d2f562dab737ab4">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">24.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Survivability of Obligations</u></font>:&#160; This Agreement sets forth several obligations which
              continue after the termination of Employee&#8217;s employment with Company, including without limitation those obligations set forth in paragraphs 1, 2, 3, 4, 5, 6, 9, 10, 11, and 12, and the Parties specifically acknowledge and agree that such
              obligations shall survive the termination of Employee&#8217;s employment for any reason.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z144a645e076444108849a4423eedb3f4">

        <tr>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">25.</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Enforcement of Restrictive Covenants</u></font>:&#160; If Employee breaches any of the provisions of
              Paragraphs 3, 9, 10, 11, or 12 of this Agreement, the Parties acknowledge and agree that such breach is likely to cause the Company serious, immediate and irreparable damage.&#160; Accordingly, if Employee breaches or threatens to breach any such
              provision, the Company shall have no adequate remedy at law and may obtain injunctive relief against Employee in any court of competent jurisdiction.&#160; The seeking and/or obtaining of such injunctive relief shall be without prejudice to the
              Company&#8217;s right to seek any other remedies available to the Company for such breach or threatened breach, including the recovery of damages from Employee.&#160; Employee agrees that the Company does not need to post a bond to obtain an injunction
              and waives Employee&#8217;s right to require such a bond.&#160;&#160; The remedies provided for under this provision are intended to be in addition to, not in place of, remedies available under federal and state laws, including the Federal Defend Trade
              Secrets Act (&#8220;FDTSA&#8221;).&#160; If the Company pursues claims against Employee under the FDTSA, the Company may recover damages from Employee that include, but are not limited to, monetary damages and punitive or exemplary damages and may obtain
              injunctive relief against Employee.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">THIS AGREEMENT HAS BEEN READ, UNDERSTOOD AND FREELY ACCEPTED BY:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z1489ef575b004695b6c5912dfe7c023e">

          <tr>
            <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman';">/s/ Joseph Chang</font></td>
            <td style="width: 10%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Dated:</font></td>
            <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"> 2020-10-16</font></font></td>
            <td style="width: 24%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 40%;">Employee</td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%;">
              <div>&#160;</div>
            </td>
            <td style="width: 20%;">
              <div>&#160;</div>
            </td>
            <td style="width: 24%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div> <br>
      </div>
      <div style="text-align: center;"> <font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">B-7</font></div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>brhc10016052_ex10-2.htm
<DESCRIPTION>EXECUTIVE SEVERANCE POLICY
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: SUMMIT
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
      <div>
        <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.2</font><br>
        </div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
        <div><br>
        </div>
        <div style="text-align: center; font-weight: bold;">EXECUTIVE SEVERANCE POLICY</div>
        <div><br>
        </div>
        <div style="text-align: center;">Amended and Restated Effective as of October 15, 2020</div>
        <div><br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" id="za76bb9cd7e744d4a81f75f1e74b6ee85" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="vertical-align: top;" colspan="3">
                <div style="text-align: center; font-weight: bold;"><u>TABLE OF CONTENTS</u></div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="3"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;"><br>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="font-weight: bold;"><u>PAGE</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;"><br>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 5%; vertical-align: top;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 1.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">DEFINITIONS</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 2.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">TERM OF POLICY</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">3<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 3.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">TERMINATION BY COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">3<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 4.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">TERMINATION BY REASON OF DEATH OR DISABILITY</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">5<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 5.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">TERMINATION BY THE COMPANY FOR CAUSE</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">6<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 6.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">VOLUNTARY TERMINATION WITHOUT GOOD REASON; RETIREMENT</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">6<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 7.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SEPARATION AND RELEASE AGREEMENT</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">6<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 8.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">RESTRICTIVE COVENANTS</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">7<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 9.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">COMPLIANCE WITH SECTION 409A</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">7<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 10.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">WITHHOLDING TAXES</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">8<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 11.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">PARACHUTE PAYMENTS</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">8<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 12.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">ADMINISTRATION</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">9<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">SECTION 13.</div>
              </td>
              <td style="width: 83%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-weight: bold;">AMENDMENT AND TERMINATION</div>
              </td>
              <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; font-weight: bold;">9<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">SECTION 14.</div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">OTHER PROVISIONS</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: center; font-weight: bold;">9<br>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>
          <div style="font-weight: bold;">EXHIBIT A</div>
        </div>
        <div>
          <div style="font-weight: bold;">EXHIBIT B</div>
          <div style="font-weight: bold;"> <br>
          </div>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
        <div style="text-align: center; font-weight: bold;">EXECUTIVE SEVERANCE POLICY</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">This Nu Skin Enterprises, Inc. Executive Severance Policy has been adopted by the Executive Compensation Committee (&#8220;<u>Committee</u>&#8221;) of the Board of Directors of the Company to apply to
          selected Executives of the Company. Eligible Executives will be eligible for coverage under the Policy for the payment of severance benefits upon termination of employment under certain circumstances, subject to the conditions set forth below.
          This Policy shall be effective as of the Effective Date as provided herein.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">This Policy supersedes any prior plan, policy, agreement or practice involving the payment of severance benefits to eligible Executives.&#160; While the Policy is in effect, any severance benefits
          provided to an eligible Executive must be paid pursuant to this Policy or pursuant to another express written agreement between Company and the eligible Executive entered into after the effective date of this Policy.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-weight: bold;"><a name="z_Toc507598313"></a>Section 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Definitions.</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">As used herein, the following terms shall have the following respective meanings:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Accrued Rights</u>&#8221; shall have the meaning given in Section 3.3 hereof.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.2&#160;&#160;&#160;&#160; &#160;&#160; &#8220;<u>Annual Target Bonus</u>&#8221; means the aggregate Bonuses that Executive is eligible to earn for the incentive periods in the fiscal year in which Executive&#8217;s Date of Termination
          occurs, assuming attainment of such corporate targets <a name="z_Hlk507246359"></a>at the &#8220;target level&#8221; (100% performance level), and disregarding any individual performance targets and regardless of whether any such Bonus has already been
          paid, as shall be established by the Committee for such fiscal year. For the avoidance of doubt, the Annual Target Bonus shall be determined assuming satisfaction of the aforementioned corporate targets, irrespective of whether such targets are
          actually achieved and whether any Bonus for a period in the fiscal year has already been paid.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Bonus</u>&#8221; means the cash incentive bonuses payable to Executive under the Third Amended and Restated Nu Skin Enterprises, Inc. 2010 Omnibus Incentive Plan (as may be amended from
          time to time), or such other or successor bonus program in which Executive participates from time to time.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Base Salary</u>&#8221; means the annual base salary in effect for the payroll period during which Executive&#8217;s employment is terminated.&#160; Bonuses, incentive pay and any taxable or
          nontaxable fringe benefits or payments are not included in the calculation of Base Salary. Base Salary shall be determined before any deferrals to any qualified or nonqualified plans of the Company and before any reduction in salary that would
          constitute Good Reason.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Cause</u>&#8221; means, subject to the conditions below, that Executive has engaged in any one of the following: (i) a material breach of this Policy or the Company&#8217;s Key Employee
          Covenants attached hereto as <u>Exhibit B</u>; (ii) any willful violation by Executive of any material law or regulation applicable to the business of the Company or any of its subsidiaries; (iii) Executive&#8217;s conviction of, or a plea of guilty
          or nolo contendere to, a felony or any willful perpetration of common law fraud; or (iv) any other willful misconduct by Executive that is materially injurious to the financial condition or business reputation of, or is otherwise materially
          injurious to, the Company or any of its subsidiaries. For purposes of the foregoing, in determining whether a &#8220;material breach&#8221; has occurred, or whether there has been a willful violation of a &#8220;material&#8221; law or regulation, the standard shall be a
          breach or violation that is, or will reasonably likely be, materially injurious to the financial condition or business reputation of, or is, or will reasonably likely be, otherwise materially injurious to, the Company or any of its subsidiaries.</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">1.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Change in Control</u>&#8221; means the consummation of any of the following transactions effecting a change in ownership or control of the Company:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During any twenty-four (24) month period, individuals who, as of the beginning of such period, constitute the Board of Directors of the Company (the &#8220;<u>Incumbent Directors</u>&#8221;)
          cease for any reason to constitute at least a majority of the Board of Directors of the Company, provided that any person becoming a director subsequent to the beginning of such period whose election or nomination for election was approved by a
          vote of at least a majority of the Incumbent Directors then on the Board of Directors of the Company (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without
          written objection to such nomination) shall be an Incumbent Director; provided, however, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to
          directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board of Directors of the Company shall be deemed to be an Incumbent Director;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any &#8220;person&#8221; (as such term is defined in the Securities Exchange Act of 1934, as amended (the &#8220;<u>Exchange Act</u>&#8221;) and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange
          Act) is or becomes a &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company&#8217;s then
          outstanding securities eligible to vote for the election of the Board of Directors of the Company (&#8220;<u>Company Voting Securities</u>&#8221;); provided, however, that the event described in this paragraph (ii) shall not be deemed to be a Change in
          Control by virtue of any of the following acquisitions:&#160; (A) by the Company or any subsidiary, (B) by any employee benefit plan (or related trust) sponsored or maintained by the Company or any subsidiary, (C) by any underwriter temporarily
          holding securities pursuant to an offering of such securities, (D) pursuant to a Non-Qualifying Transaction, as defined in paragraph (iii), or (E) by any person of Company Voting Securities from the Company, if a majority of the Incumbent
          Directors approves in advance the acquisition of beneficial ownership of fifty percent (50%) or more of Company Voting Securities by such person;</div>
        <div style="text-align: justify; text-indent: 108pt;"> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%%%-->
        <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; The consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its subsidiaries that requires the
          approval of the Company&#8217;s stockholders, whether for such transaction or the issuance of securities in the transaction (a &#8220;<u>Business Combination</u>&#8221;), unless immediately following such Business Combination:&#160; (A) more than fifty percent (50%) of
          the total voting power of (x) the corporation resulting from such Business Combination (the &#8220;<u>Surviving Corporation</u>&#8221;), or (y) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of at least
          ninety percent (90%) of the voting securities eligible to elect directors of the Surviving Corporation (the &#8220;<u>Parent Corporation</u>&#8221;), is represented by Company Voting Securities that were outstanding immediately prior to such Business
          Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as
          the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan (or related trust) sponsored or maintained by the Surviving
          Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or indirectly, of fifty percent (50%) or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent
          Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation)
          following the consummation of the Business Combination were Incumbent Directors at the time of the Board of Directors of the Company&#8217;s approval of the execution of the initial agreement providing for such Business Combination (any Business
          Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a &#8220;<u>Non&#8209;Qualifying Transaction</u>&#8221;); or</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or the consummation of a sale of all or substantially all of the Company&#8217;s
          assets.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Company</u>&#8221; means Nu Skin Enterprises, Inc., a Delaware corporation.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986, as amended.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Committee</u>&#8221; means the Executive Compensation Committee of the Board of Directors of the Company.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.10&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Date of Termination</u>&#8221; means the effective date of the relevant Executive&#8217;s termination of employment with the Company.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.11&#160;&#160; &#160; &#160; &#8220;<u>Disability</u>&#8221; means a physical or mental impairment which, the Committee determines, after consideration and implementation of reasonable accommodations, precludes the Executive
          from performing Executive&#8217;s essential job functions for a period longer than three (3) consecutive months or a total of one hundred twenty (120) days in any twelve (12) month period.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.12&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Effective Date</u>&#8221; means, with respect to this amendment and restatement of the Policy, October 15, 2020, or such later date as determined by the Committee with respect to an
          Executive. The original Effective Date of the Policy was March 8, 2018.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.13&#160; &#160;&#160;&#160; &#8220;<u>Executive</u>&#8221; means the executive employees of the Company who are eligible to participate in the Policy as set forth in Schedule A to this Policy, as it may be amended from time
          to time.&#160; Schedule A may be amended at any time to add additional executive employees or to remove executive employees from eligibility to participate in this Policy as Executives.</div>
        <div style="text-align: justify; text-indent: 72pt;"> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">1.14&#160;&#160;&#160;&#160;&#160; &#8220;<u>Good Reason</u>&#8221; means Executive&#8217;s voluntary resignation for any of the following events that result in a material negative change to Executive: (i) without Executive&#8217;s consent, a
          material reduction in the scope of Executive&#8217;s duties and responsibilities or the level of management to which Executive reports; (ii) without Executive&#8217;s consent, a reduction in Base Salary (other than an across-the-board reduction of not more
          than ten percent (10%) applicable to all senior executive officers); (iii) without Executive&#8217;s consent, a material reduction in Executive&#8217;s benefits in the aggregate (in terms of benefit levels, other than an across-the-board reduction) from
          those provided to Executive under any employee benefit plan, program and practice in which only the Executives (and no other employees of the Company) participate, provided that such material reduction occurs within six (6) months immediately
          prior to or following the consummation of a Change in Control; (iv) without Executive&#8217;s consent, a relocation of Executive&#8217;s principal place of employment of more than fifty (50) miles from Executive&#8217;s primary residence, (v) a material breach of
          any provision of this Policy by the Company, or (vi) the failure of the Company to have a successor entity specifically assume this Policy within ten (10) business days after the Change in Control.&#160; Notwithstanding the foregoing, Good Reason
          shall only be found to exist if Executive, not later than ninety (90) days after the initial occurrence of an event deemed to give rise to a right to terminate for Good Reason, has provided thirty (30) days written notice to the Company prior to
          Executive&#8217;s resignation indicating and describing the event resulting in such Good Reason, and the Company does not cure such event (other than the event in clause (vi)), which shall not be subject to cure) within ninety (90) days following the
          receipt of such notice from Executive.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.15&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Policy</u>&#8221; means this Nu Skin Enterprises, Inc. Executive Severance Policy.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">1.16&#160;&#160;&#160;&#160;&#160; &#8220;<u>Pro Rata Earned Bonus</u>&#8221; means the pro-rata portion of the Executive&#8217;s earned bonus, if any, for each outstanding bonus cycle as of the date on which termination of employment
          occurs, based upon attainment of such corporate targets, and disregarding any individual performance targets, as shall be established by the Committee for such bonus cycle (determined by multiplying the amount of the actual earned bonus that
          would be payable for the bonus cycle by a fraction, the numerator of which is the number of days during the bonus cycle that the Executive is employed by the Company and the denominator of which is the full number of days in the bonus cycle); <font style="color: rgb(0, 0, 0);">provided, however, Executive shall not be entitled to a Pro Rata Earned Bonus for an annual bonus cycle if Executive&#8217;s termination date is earlier than March 31</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup><font style="color: rgb(0, 0, 0);"> of the year of termination</font>.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598314"></a>Section 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Term of Policy</u>.<br>
        </div>
        <div style="font-weight: bold; margin-left: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">The term of this Policy shall begin on the Effective Date and shall continue in effect until modified or terminated by the Company pursuant to Section 13 hereof.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-weight: bold;"><a name="z_Toc507598315"></a>Section 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Termination by Company without Cause or by Executive for Good Reason</u>.</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">If the Company terminates Executive&#8217;s employment during the term of the Policy without Cause, or if Executive terminates his or her employment during the term of the Policy for Good Reason, then,
          subject to Sections 7 and 8 below, Executive shall be entitled to the following rights and benefits under this Section 3:</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Lump Sum Payment</u>. Executive shall be entitled to either the lump sum payment described in Section 3.1(i) or the lump sum payment described in Section 3.2(ii).</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zaa56bd4d10fd4fa2bcb9a09268356f2d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 108pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(i)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Termination without Cause or for Good Reason in Connection with Change in Control</u></font><font style="font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">In the event that the Company terminates the employment of Executive during the term of the Policy without Cause or Executive terminates his or her employment during the term of the Policy for
          Good Reason, and the applicable Date of Termination occurs (A) within six (6) months prior to and in connection with a Change in Control (as determined by the Committee), or (B) within two (2) years following such Change in Control, then the
          Company will pay Executive a lump sum payment equal to the product of: (I) the sum of (A) Executive&#8217;s Base Salary as of the Date of Termination plus (B) the Annual Target Bonus; and (II) the Multiplier specified in Schedule A.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">The lump sum amount described above in this Section 3.1(i) shall be paid in a lump sum payment within 30 days of the Date of Termination, but in no event earlier than the date the Separation and
          Release Agreement described in Section 7 becomes effective, or later than March 15th of the year following the year in which the Date of Termination occurs. In addition, the Company shall pay Executive the Pro Rata Earned Bonus.&#160; The Pro Rata
          Earned Bonus shall be paid to Executive at the same time as bonuses are paid to other executive officers of the Company for each outstanding bonus period that is considered part of the Pro Rata Earned Bonus, but in no event earlier than the date
          the Separation and Release Agreement described in Section 7 becomes effective, or later than March 15th of the year following the year in which the Date of Termination occurs.</div>
        <div>&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z6d0a231056d441b1b75824a0131bb68e" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="width: 108pt;">&#160;</td>
                <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;">(ii)</div>
                </td>
                <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><u>Other Termination without Cause or for Good Reason</u>.</div>
                </td>
              </tr>

          </table>
        </div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">If the Company terminates Executive&#8217;s employment during the term of the Policy without Cause, or if Executive terminates his or her employment during the term of the Policy for Good Reason, and
          Executive is not eligible for payment pursuant to Section 3.1(i), then the Company will pay Executive a lump sum payment equal to the product of: (A) Executive&#8217;s Base Salary as of the Date of Termination and (B) the Multiplier specified in
          Schedule A.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">The lump sum payment described above in this Section 3.1(ii) shall be paid in a lump sum payment within 30 days after the Date of Termination, but in no event earlier than the date the Separation
          and Release Agreement described in Section 7 becomes effective, or later than March 15th of the year following the year in which the Date of Termination occurs. In addition, the Company shall pay Executive the Pro Rata Earned Bonus.&#160; The Pro Rata
          Earned Bonus shall be paid to Executive at the same time as bonuses are paid to other executive officers of the Company for each outstanding bonus period that is considered part of the Pro Rata Earned Bonus, but in no event earlier than the date
          the Separation and Release Agreement described in Section 7 becomes effective, or later than March 15th of the year following the year in which the Date of Termination occurs.&#160; For the avoidance of doubt, Executive shall not be eligible for
          payment pursuant to this Section 3.1(ii) if Executive is eligible for payment pursuant to Section 3.1(i).</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>COBRA Payment</u>. Executive shall be eligible for continuation of coverage for Executive and Executive&#8217;s eligible dependents under the Company&#8217;s group health plan(s) as required
          under COBRA, at Executive&#8217;s sole expense at the applicable COBRA rate for such plan(s), subject to the following: the Company shall pay to Executive a lump sum payment equal to the aggregate employer and employee cost of twelve (12) months of
          health care continuation coverage under the Company&#8217;s medical, dental, prescription drug and vision care group health plans as in effect from time to time. The lump sum payment contemplated under this Section 3.2 shall be paid to Executive as
          soon as administratively practicable following the Date of Termination, but in no event earlier than the date the Separation and Release Agreement described in Section 7 becomes effective, or later than March 15th of the year following the year
          in which the Date of Termination occurs.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Accrued Rights</u>. As soon as administratively practicable following the Date of Termination, or as otherwise provided below, the Company will pay or provide Executive with (i)
          all accrued but unpaid base salary through the Date of Termination, (ii) any previously awarded but unpaid Bonus for a completed bonus cycle prior to the Date of Termination, payable at the time such Bonuses regularly are paid, (iii) any
          unreimbursed business expenses that are reimbursable under the Company&#8217;s business expense policy, (iv) all rights and benefits under the employee benefit plans of the Company in which Executive is then participating, payable at the times set
          forth in such plans, and (v) any other payments as may be required under applicable law (collectively, the &#8220;<u>Accrued Rights</u>&#8221;).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Treatment of Equity Awards</u>. The vesting and exercise of any equity awards that may be held by Executive as of the Date of Termination shall be determined in accordance with
          the applicable equity incentive plan and grant documentation for that Executive.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">3.5&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Additional Rights</u>. Except as provided in this Section 3, Executive&#8217;s participation under any benefit plan, program, policy or arrangement sponsored or maintained by the
          Company shall cease and be terminated on the Date of Termination. Without limiting the generality of the foregoing, Executive&#8217;s eligibility for and active participation in any tax qualified retirement or pension plans maintained by the Company
          will end as of the Date of Termination and Executive will earn no additional benefits under those plans after that date. Executive shall be treated as a terminated employee for purposes of all such benefit plans and programs effective as of the
          Date of Termination, and shall receive all payments and benefits due under such plans and programs in accordance with the terms and conditions thereof.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598316"></a>Section 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination by Reason of Death or Disability</u>.<br>
        </div>
        <div style="font-weight: bold; margin-left: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">In the event that the employment of Executive is terminated during the term of the Policy by reason of Executive&#8217;s death or Disability, then, subject to Sections 7 and 8 below, Executive shall be
          entitled to the following rights and benefits under this Section 4:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">4.1&#160;&#160; &#160;&#160;&#160;&#160; <u>Salary Continuation (Disability Only)</u>. In the event that the employment of Executive is terminated during the term of the Policy by reason of Executive&#8217;s Disability, the
          Company will pay Executive salary continuation at an annual rate equal to Executive&#8217;s then-current Base Salary until the earlier of (i) the date Executive is eligible for disability payments under the Company&#8217;s group disability policies (as
          determined by the Company) or (ii) ninety (90) days following the Date of Termination by reason of Disability.&#160; Salary continuation under this Section 4.1 shall be paid in equal bi-monthly installments in accordance with the Company&#8217;s customary
          payroll practices.</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Bonus</u>. The Company will pay the Pro Rata Earned Bonus, which shall be paid on the date that Bonuses are normally paid, but in no event earlier than the date the Separation and
          Release Agreement described in Section 7 becomes effective, or later than March 15th of the year following the year in which the Date of Termination occurs.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Accrued Rights</u>. As soon as administratively practicable following the Date of Termination, the Company will pay or provide Executive with the Accrued Rights.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Treatment of Equity Awards</u>. The vesting and exercise of any equity awards that may be held by Executive as of the Date of Termination shall be determined in accordance with
          the applicable equity incentive plan and grant documentation for that Executive.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598317"></a>Section 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Termination by the Company for Cause</u>.<br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">The Company may terminate Executive&#8217;s employment for any reason and at any time, with or without Cause. In the event that the Company terminates the employment of Executive during the term of the
          Policy for Cause, the Company will pay or provide Executive with the Accrued Rights and no other benefits.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-weight: bold;"><a name="z_Toc507598318"></a>Section 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Voluntary Termination without Good Reason; Retirement</u>.</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">Executive shall not be entitled to any payments or benefits under this Policy (other than Accrued Rights) by reason of Executive&#8217;s voluntary termination of employment from the Company without
          Good Reason. This Policy shall have no effect on the rights and benefits to which an Executive may be entitled upon retirement under (without limitation) any retirement or savings plan of the Company, nor under any of the Company&#8217;s equity
          incentive or cash incentive plans (including applicable award agreements), non-qualified deferred compensation plans, key employee death plans, and other health and miscellaneous benefit plans, each of which shall be governed exclusively by the
          terms of such plans and agreements, as applicable. Notwithstanding the foregoing, Company shall pay Executive a lump sum equal to 75% of Executive&#8217;s base salary under the terms of the Key Employee Covenants if Company elects, in its sole
          discretion, to enforce the non-compete.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598319"></a>Section 7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Separation and Release Agreement</u>.<br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">To the extent permitted under applicable law, as a condition precedent to receiving any payments and benefits as provided under this Policy, Executive must execute a general release of claims
          (the &#8220;<u>Separation and Release Agreement</u>&#8221;), substantially in the form attached as <u>Exhibit A</u> hereto, and such Separation and Release Agreement must become irrevocable, by the sixtieth (60<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day following the Date of Termination. If Executive fails to execute and deliver the Separation and Release Agreement, or revokes the Separation and Release Agreement, Executive shall not be
          entitled to receive the payments and benefits described herein (other than Accrued Rights). For purposes of this Policy, the Separation and Release Agreement shall be considered to have been executed by Executive if it is signed by Executive&#8217;s
          legal representative in the case of legal incompetence or on behalf of Executive&#8217;s estate in the case of Executive&#8217;s death.</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="font-weight: bold; margin-left: 36pt;">Section 8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Restrictive Covenants</u>.<br>
        </div>
        <div style="font-weight: bold; margin-left: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Key Employee Covenants Agreement</u>. In consideration of Executive&#8217;s employment by the Company and the additional rights and benefits provided to Executive by this Policy, on the
          Effective Date or such later date when an individual becomes an Executive, Executive will agree to and execute the Key Employee Covenants Agreement substantially in the form attached as <u>Exhibit B</u> hereto or in such other form approved by
          the Committee.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transfer of Duties</u>.&#160; Upon termination of employment, Executive must cooperate with the orderly transfer of his or her duties as requested by the Company.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">8.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Return of Property</u>.&#160; Upon termination of employment, Executive must return all Company property by a date specified by the Company.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598321"></a>Section 9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Compliance with Section 409A</u>. <br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">9.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any other provision of this Policy to the contrary, the parties agree that this Policy is intended to comply with or be exempt from Code Section 409A and the
          regulations and guidance promulgated thereunder (collectively &#8220;<u>Section 409A</u>&#8221;), and all provisions of this Policy shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section
          409A.&#160; The Company and Executive intend that, to the maximum extent possible, any amounts paid pursuant to this Policy shall qualify as a short-term deferral pursuant to Section 409A or as separation pay exempt from Section 409A. In no event will
          the Company or its affiliates be liable for any additional tax, interest or penalties that may be imposed on Executive under Section 409A or any damages for failing to comply with Section 409A.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">9.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any other provision of this Policy to the contrary, to the extent that any payment under this Policy constitutes &#8220;nonqualified deferred compensation&#8221; under Section
          409A, the following shall apply to the extent Section 409A is applicable to such payment:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any payable that is triggered upon the Executive&#8217;s termination of employment shall be paid only if such termination of employment constitutes a &#8220;separation from service&#8221; under
          Section 409A.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; All in-kind benefits, expenses or other reimbursements paid pursuant to this Policy that are taxable income to Executive shall be paid no later than the end of the calendar year
          next following the calendar year in which Executive incurs such expense.&#160; With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Section 409A, (a) the right to
          reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (b) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses
          eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year; and (c) such payments shall be made on or before the last day of Executive&#8217;s taxable year following the taxable year in which the expense occurred.</div>
        <div style="text-align: justify; text-indent: 108pt;"> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; In the event that Executive is deemed on the date of termination to be a &#8220;specified employee&#8221; as defined in Section 409A, then with regard to any payment or the provision of any
          benefit that is subject to Section 409A and is payable on account of a separation from service (as defined in Section 409A), such payment or benefit shall be delayed for until the earlier of (a) the first business day of the seventh calendar
          month following such termination of employment, or (b) Executive&#8217;s death.&#160; Any payments delayed by reason of the prior sentence shall be paid in a single lump sum, without interest thereon, on the date indicated by the previous sentence and any
          remaining payments due under this Policy shall be paid as otherwise provided herein.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">9.3</font><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">For purposes of Section 409A, Executive&#8217;s right to receive any installment payments under this Policy (whether severance payments, reimbursements or
            otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment pay</font>ment hereunder shall at all times be considered a separate and distinct payment.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">9.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To the extent required to avoid the imposition of additional taxes and penalties under Section 409A, amounts payable under this Policy on termination of employment will not be paid
          until Executive experiences a separation from service within the meaning of Section 409A as specified above.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">9.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision of this Policy to the contrary, in no event shall the timing of Executive&#8217;s execution of the Separation and Release Agreement, directly or indirectly,
          result in Executive designating the calendar year of payment, and if a payment pursuant to this Policy that is subject to execution of the Separation and Release Agreement could be made in more than one taxable year, based on timing of the
          execution of the Separation and Release Agreement, payment shall be made in the later taxable year.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598322"></a>Section 10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Withholding Taxes</u>.<br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">All compensation payable pursuant to this Policy shall be subject to all applicable federal, state and local tax withholding.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;"><a name="z_Toc507598323"></a>Section 11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Parachute Payments</u>.</font><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">Notwithstanding anything in this Policy to the contrary, in the event the Company determines that any payment or distribution in the nature of compensation (within the meaning of Code Section
          280G(b)(2)) to or for the benefit of Executive, whether paid or payable pursuant to this Policy or otherwise would be subject to the excise tax imposed by Code Section 4999, then Executive shall be entitled to receive (i) the greatest amount so
          that no portion the payments shall be an excess parachute payment (the &#8220;<u>Limited Amount</u>&#8221;), or (ii) if the amount of payments otherwise paid or provided (without regard to clause (i)) reduced by all taxes applicable thereto (including, for
          the avoidance of doubt, the excise tax imposed by Code Section 4999) would be greater than the Limited Amount reduced by all taxes applicable thereto, then the amount of payments shall be the amount otherwise payable. Any reductions described in
          the preceding sentence shall be done in the manner that is least economically disadvantageous to Executive. Where the decision to cut back between two amounts is economically equivalent, but the amounts are payable at different times, the amounts
          will be reduced on a pro rata basis.</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="font-weight: bold; margin-left: 36pt;">Section 12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Administration</u>.<br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">The Committee is responsible for the administration of this Policy and shall have all powers and duties necessary to fulfill its responsibilities. The Committee shall have full power and
          discretion to interpret the Policy and related documents, to resolve ambiguities, inconsistencies and omissions, to determine any question of fact, and to determine the rights and benefits, if any, of any Executive or other employee, in
          accordance with the provisions of the Policy. The Committee shall also have the authority to waive any restrictions with respect to participation in the Policy or the maturity of benefits under the Policy for any specific Executive where, in the
          opinion of the Committee, it is reasonable to do so and does not prejudice the rights of the particular Executive under the Policy and it does not cause the Executive to be subject to adverse tax treatment under Section 409A. The Committee&#8217;s
          decision with respect to any matter shall be final and binding on all parties concerned. The Committee may, from time to time, by action of its appropriate officers, delegate to designated persons, committees, or entities the right to exercise
          any of its powers or the obligation to carry out its duties under the Policy.</div>
        <div>&#160;</div>
        <div style="font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598325"></a>Section 13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendment and Termination</u>.<br>
        </div>
        <div style="font-weight: bold; margin-left: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">The Company reserves the right to amend or terminate this Policy at any time and in any manner, subject to the following: (i) no amendment or termination of this Policy made during the period
          beginning six (6) months prior to a Change in Control and continuing until the second anniversary of the Change in Control, shall become effective until the second anniversary of a Change in Control, provided that the Company shall have the
          ability to make any amendment required under applicable law (including without limitation any amendments necessary to comply with Section 409A) at any time; (ii) if any modification of this Policy decreases the benefits available to an Executive
          through this Policy (such modification, an &#8220;<u>Adverse Change</u>&#8221;), the Company shall give written notice to the impacted Executive of the Adverse Change; and (iii) the Adverse Change shall not be effective with respect to the Executive any
          sooner than one (1) year from the date on which the notice described in (ii) above was provided to the impacted Executive. Notwithstanding the foregoing, (x) no amendment or termination of the Policy shall affect the rights of an Executive whose
          Date of Termination has occurred prior to the date of such amendment or termination of the Policy and who remains entitled to severance payments or benefits under this Policy, and (y) the requirements described in (ii) and (iii) above, with
          respect to an Executive impacted by an Adverse Change, may be waived in writing by the Executive.</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-weight: bold; margin-left: 36pt;"><a name="z_Toc507598326"></a>Section 14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Provisions</u>.<br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">14.1&#160;&#160;&#160;&#160;&#160; <u>Acknowledgment</u>. Executive acknowledges that this Policy does not constitute a contract of employment or impose on the Company any obligation to retain Executive as an employee
          and that this Policy does not prevent Executive from terminating employment at any time.</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 72pt;">14.2&#160;&#160;&#160;&#160;&#160;&#160; <u>Non-Duplication of Benefits</u>. The benefits under this Policy are not intended to duplicate any other benefits provided by the Company in connection with the termination of an
          employee&#8217;s employment, such as wage replacement benefits, pay-in-lieu-of-notice, severance pay, or similar benefits under any other benefit plans, severance programs, employment contracts, or applicable federal or state laws, such as the WARN
          Acts. Should such other benefits be payable, the benefits under this Policy will be reduced accordingly or, alternatively, benefits previously paid under this Policy will be treated as having been paid to satisfy such other benefit obligations.
          In either case, the Company will determine how to apply this provision and may override other provisions in this Policy in doing so.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">14.3&#160;&#160;&#160;&#160;&#160;&#160; <u>Construction</u>.&#160; This Policy shall be governed and enforced in accordance with the laws of the State of Utah, and any litigation between the parties relating to this Policy shall
          be conducted in the courts of Utah County.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">14.4&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>.&#160; If any provision of this Policy, or the application of such provision to any person or in any circumstance, is found by a court of competent jurisdiction to be
          unenforceable for any reason, such provision may be modified or severed from this Policy to the extent necessary to make such provision unenforceable against such person or in such circumstance. Neither the unenforceability of such provision nor
          the modification or severance of such provision will affect (i) the enforceability of any other provision of this Policy or (ii) the enforceability of such provision against any person or in any circumstance other than those against or in which
          such provision is found to be unenforceable.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">14.5&#160;&#160;&#160;&#160;&#160; <u>Records</u>.&#160; The records of the Company with respect to the determination of eligibility, employment history, Accrued Rights, Base Salary, Bonus, and any and all other relevant
          matters shall be conclusive for all purposes of this Policy.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt;">14.6&#160;&#160;&#160;&#160; <u>Entire Agreement</u>.&#160; The Company and Executive understand and agree that this Policy shall constitute the entire understanding between them regarding the subject matter contained
          herein, and that all prior understandings regarding these matters are hereby superseded and replaced, unless specifically provided otherwise in this Policy.</div>
        <div>&#160;</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;"><u>SCHEDULE A</u></div>
        <div>&#160;</div>
        <div style="text-align: center; font-style: italic;">Executives</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" id="z5357ff31933a4dbe92018dc00cc93456" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); width: 1%;" colspan="3" rowspan="1">&#160;
                <div style="text-align: center; font-weight: bold;">Name and Title of Executive</div>
              </td>
              <td style="width: 13%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Multiplier for </div>
                <div style="text-align: center; font-weight: bold;">Section 3.1(i)</div>
              </td>
              <td style="width: 13%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Multiplier for </div>
                <div style="text-align: center; font-weight: bold;">Section 3.1(ii)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><br>
              </td>
              <td style="width: 2%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;</div>
              </td>
              <td style="width: 71%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>Ritch Wood, Chief Executive Officer</div>
              </td>
              <td style="width: 13%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">2</div>
              </td>
              <td style="width: 13%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">1.5</div>
              </td>
            </tr>
            <tr>
              <td style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1"><br>
              </td>
              <td style="width: 2%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;</div>
                <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;</div>
                <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;</div>
                <div style="text-indent: -18pt; margin-left: 18pt;">&#8226;</div>
              </td>
              <td style="width: 71%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-indent: -18pt; margin-left: 18pt;">Ryan Napierski, President</div>
                <div>Mark Lawrence, Executive Vice President and Chief Financial Officer</div>
                <div>D. Matthew Dorny, Executive Vice President, and General Counsel</div>
                <div>Joseph Chang, Executive Vice President of Product Development and Chief Scientific Officer</div>
              </td>
              <td style="width: 13%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">1.5</div>
              </td>
              <td style="width: 13%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: center;">1.25</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT A</u></div>
        <div>&#160;</div>
        <div>
          <!--PROfilePageNumberReset%Num%1%%%-->
          <div>
            <div>
              <div style="text-align: center; font-weight: bold;">SEPARATION AND RELEASE AGREEMENT</div>
              <div>&#160;</div>
              <div style="text-align: justify;">This Separation and Release Agreement (this &#8220;Agreement&#8221;) is entered into effective as of ____________, by and between Nu Skin Enterprises, Inc., a Delaware corporation (the &#8220;Company&#8221;) and _________________,
                an individual (&#8220;Employee&#8221;). The Company and Employee are sometimes hereinafter referred to as &#8220;party&#8221; or &#8220;parties.&#8221;</div>
              <div>&#160;</div>
              <div style="text-align: center;">RECITALS</div>
              <div>&#160;</div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf14336a698164a20a48db2b0de42d0d8">

                  <tr>
                    <td style="width: 36pt; vertical-align: top;">A.</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div>Employee&#8217;s employment with the Company terminated on ____________ (the &#8220;Employment Termination Date&#8221;).</div>
                    </td>
                  </tr>

              </table>
              <div>&#160;</div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab1d2ae0a15f43eaa56e76e288a2c82b">

                  <tr>
                    <td style="width: 36pt; vertical-align: top;">B.</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div>The Company and Employee mutually agree it is in the best interests of both to enter into a mutual understanding, settlement and compromise of all claims and disputes, if any, between them.</div>
                    </td>
                  </tr>

              </table>
              <div>&#160;</div>
              <div style="text-align: center;">AGREEMENT</div>
              <div>&#160;</div>
              <div style="text-align: justify;">In consideration of the mutual promises and covenants set forth herein, and for other good and valuable consideration, the receipt, adequacy, and legal sufficiency of which are hereby acknowledged, the
                parties hereby mutually agree as follows:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company agrees to make certain payments to Employee as set forth in the Nu Skin Enterprises, Inc. Executive Severance Policy (the &#8220;Severance Policy&#8221;). Except as expressly
                set forth in this Agreement, or in a specific plan document (e.g. 401(k) plan etc., stock option plan etc.), Employee shall not be entitled to any further compensation or benefits from the Company.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; In consideration for the payments set forth in Section 1 hereof, Employee, and all persons and entities claiming by, through or under Employee, hereby completely release the
                Company and any person or entity that controls, is controlled by or is under common control with the Company, including without limitations, any direct or indirect parent or subsidiary of the Company or any officer, director, shareholder,
                employee, attorney, or agent of the Company from all claims, charges, demands, grievances, and/or causes of action which Employee had, has, or may claim to have based on, arising from, or relating to Employee&#8217;s employment with the Company
                or the termination thereof, including, without limitation, any claims, charges, demands, grievances, and/or causes of action under:</div>
              <div style="text-align: justify;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z0d1039f0bbee4b5ea47e04d6bbcb5db4">

                    <tr>
                      <td style="width: 100.00%;">
                        <div>&#160;</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="float: left; width: 33%;" id="EFPFTCL">
                <div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zaf3998cf61684c5b985adbd24baa2935" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Equal Pay Act;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zde5cc08e940348578dcb96b8fb479c28" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Fair Labor Standards Act;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="z226dbe902ad04104b2b42f6096dbb6df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the National Labor Relations Act;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="z52533687c1894ca9af4edefe2deb8590" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Title VII of the Civil Rights Act of 1964;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="ze0769115969d416593798af57d3c8a3d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Post-Civil War Reconstruction Acts (42 U.S.C. &#167;&#167;&#160;1981-1988);</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="z643c5db6717049c8a88cc48b9d97e5a1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Americans with Disabilities Act of 1990;</div>
                          </td>
                        </tr>

                    </table>
                    <div>
                      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="0e18dbc7f81447259dee7c54b4a191d7" class="DSPFListTable">

                          <tr>
                            <td style="width: 18pt; vertical-align: top; align: right;">
                              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                            </td>
                            <td style="width: auto; vertical-align: top;">
                              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">any claim in tort or contract, or for promissory estoppel or violation of a covenant of good faith and fair dealing;</div>
                            </td>
                          </tr>

                      </table>
                      <br>
                    </div>
                  </div>
                </div>
              </div>
              <div style="float: left; width: 32%; margin-left: 1%;" id="EFPFTCL">
                <div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="z09ae752d8d384e419a932003bc642604" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Rehabilitation Act of 1973;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zb316fae7aa3b423faed019b5f62fbeea" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Employee Retirement Income Security Act of 1974;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zeaa4e32296e04502a4ab3ae3645abe63" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Family and Medical Leave Act of 1993;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zf698b15bc7b6443ea72cdc6a96c0dad6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Genetic Information Nondiscrimination Act of 2008;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="z3d0440e20c8647bb9aaf3cc7e590039b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Utah Antidiscrimination Act;</div>
                          </td>
                        </tr>

                    </table>
                    <div>
                      <div>
                        <table cellspacing="0" cellpadding="0" id="ze4985687fd17440b89e07028c417caa0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                            <tr>
                              <td style="width: 18pt; vertical-align: top; align: right;">
                                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                              </td>
                              <td style="width: auto; vertical-align: top;">
                                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">any and all claims for attorneys&#8217; fees, costs, and/or penalties;</div>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div style="float: right; width: 33%;" id="EFPFTCR">
                <div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zb616720a07614369afbded2d2557799a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">any other federal or state statute;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zef3c7f9c11014b9f87510ed6cf1a9ffe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">any claim for unpaid compensation or benefits;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zbcf254b508414412a520ec257abc4448" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">any claim of retaliation or whistleblower discrimination;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="ze4294386a6264eee8bca9133168ad096" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">any claim of wrongful discharge against public policy;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
                <div>
                  <div>
                    <table cellspacing="0" cellpadding="0" id="zaa94c17f8f494d759d6c5629f12f3a60" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                        <tr>
                          <td style="width: 18pt; vertical-align: top; align: right;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</div>
                          </td>
                          <td style="width: auto; vertical-align: top;">
                            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">and any other claim arising out of common law or federal, state, or local law.</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
              <div style="clear: both;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z30933cd01dbc4709a5bc81e65f8cc924">

                    <tr>
                      <td style="width: 100.00%;">
                        <div>&#160;</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
                <div style="page-break-after:always;" id="DSPFPageBreak">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div style="text-align: justify; text-indent: 36pt;">The foregoing release also includes, without limitation, release of any claims for wrongful discharge, breach of express or implied contract of employment, employment-related torts,
                personal injury (whether physical or mental), or any other claims in any way related to Employee&#8217;s employment with or separation from the Company. Employee acknowledges and agrees that Employee has not been discriminated against in any
                manner prohibited by law during Employee&#8217;s employment with the Company or with regard to Employee&#8217;s separation from employment with the Company.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">Notwithstanding the foregoing, Employee does not waive any rights to unemployment insurance benefits or worker&#8217;s compensation benefits.&#160; Employee further understands that nothing in this
                Section 2 prohibits Employee from paying COBRA premiums to maintain Employee&#8217;s participation in the Company&#8217;s group health plan to the extent allowed by law and subject to the terms, conditions, and limitations set forth in the Company&#8217;s
                group health plan.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; Employee acknowledges that Employee is waiving and releasing any rights Employee may have under the Age Discrimination in Employment Act of 1967 (&#8220;ADEA&#8221;) and that this waiver
                and release is knowing and voluntary. Employee and the Company agree that this waiver and release does not apply to any rights or claims that may arise under ADEA after the effective date of this Agreement.&#160; Employee acknowledges that the
                consideration given for this waiver and release agreement is in addition to anything of value to which Employee was already entitled.&#160; Employee further acknowledges that Employee has been advised by this writing that:</div>
              <div>&#160;</div>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2624ec1d5018424685cfe7ee906fc3d6">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 18pt; vertical-align: top;">a.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>Employee should consult with an attorney prior to executing this Agreement;</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7d9c620d5f9d46a9bfefcb4732c79d87">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 18pt; vertical-align: top;">b.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>Employee has at least 21 days within which to consider this Agreement, although Employee may accept the terms of this Agreement at any time within those 21 days, provided that changes to this Agreement shall not extend or restart
                      the running of the 21-day period;</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6d523065de194213be42044d7e39869f">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 18pt; vertical-align: top;">c.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>Employee has at least seven days following the execution of this Agreement by the parties to revoke this Agreement; and</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z258485e6e3df412683e50470d0356a67">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 18pt; vertical-align: top;">d.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>this Agreement will not be effective until the revocation period has expired.</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; Employee acknowledges that Employee&#8217;s obligations under the Key Employee Covenants Agreement continue after the termination of Employee&#8217;s employment for any reason.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; At the time of termination of Employee&#8217;s employment, Employee shall return to the Company all confidential information, computers, laptops, cell phones, passwords, and all other
              equipment or materials owned by the Company in the possession of Employee.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-indent: 36pt;">6.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; Nothing in this Agreement waives or releases any rights or claims that, by law, cannot be waived or released.&#160; For example, nothing in this Agreement shall be construed to prohibit Employee from
              volunteering information or documents, filing a charge with, or otherwise participating in any investigation or proceedings conducted by the Equal Employment Opportunity Commission, the National Labor Relations Board, the Securities and
              Exchange Commission, or any other federal, state, or local government agency or commission (collectively &#8220;Government Agencies&#8221; and each a &#8220;Government Agency&#8221;) charged with enforcement of any law.&#160; Further, nothing in this Agreement affects
              claims under statutes that prohibit an employee from waiving or releasing such claims, including but not limited to claims for unemployment benefits, workers&#8217; compensation benefits, vested benefits under an ERISA plan, or statutory claims
              which, in accordance with the statutes creating such claims, may not be waived or released.&#160; Notwithstanding the foregoing, Employee agrees that by executing this Agreement he/she affirms that the payment received pursuant to Section 1 of
              this Agreement are the only legal remedy he/she may receive as compensatory damages or for lost back or front wages and waives any right to recover personally, monetary damages or any other individual relief as a result of any charge,
              complaint, or lawsuit filed by Employee or by anyone, including but not limited to a Government Agency, on his/her behalf.&#160; This Agreement does not limit Employee&#8217;s right to receive any award unrelated to any claim for damages for information
              provided to any Government Agency.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">7.&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; Employee represents that he/she has no lawsuits, claims, or actions pending in his/her name, or on behalf of any other person or entity, against the Company in any state or
              federal court, any arbitral forum, or any state, federal, or local administrative or governmental agency.&#160; Employee also promises to opt out of any class or representative action and to take such other steps as he/she has the power to take to
              disassociate him/herself from and waive any rights or remedies that might be received from any class or representative action seeking relief against the Company and/or any other Released Party regarding any of the released Claims.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">8.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; This Agreement is a negotiated settlement of all claims, charges, demands, grievances, and/or causes of action, if any, between the parties.&#160; This Agreement does not constitute
              an admission by the Company, and the Company specifically denies that the Company has violated any contract, law, or regulation or that it has discriminated against Employee or otherwise infringed upon Employee&#8217;s rights and privileges or done
              any other wrongful act.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">9.&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; This Agreement is confidential information owned by the Company.&#160; No party may disclose the contents of this Agreement except to the extent required by law.&#160; Notwithstanding the
              foregoing, Employee may disclose the terms of the Agreement to Employee&#8217;s attorney or accountants for the purposes of obtaining advice or professional services or to Employee&#8217;s immediate family (spouse and children).&#160; If Employee discloses
              the terms of this Agreement to Employee&#8217;s attorney, accountant, or his/her immediate family, Employee will advise such individuals that they must not disclose the terms of this Agreement except to the extent required by law.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If Employee violates or breaches this Agreement, then this Agreement shall remain in full force and effect except that the Company will be entitled to recover from Employee the
              monies paid pursuant to Section 1 above, attorneys&#8217; fees and any other remedy available to the Company pursuant to this Agreement or otherwise.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Should Employee return to work for the Company prior to the elapse of time being compensated for under this Agreement, there will be a pro-rata return of such severance payment in
              a lump sum by the Employee to the Company before any re-employment will be permitted to take place.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The provisions of this Agreement are severable.&#160; Should any provision hereof be voidable or unenforceable under applicable law, such voidable, or unenforceable provision shall not
              affect the validity of any other clause or provision, which shall remain in full force and effect.&#160; In addition, it is the intention and agreement of the parties that all of the terms and conditions hereof be enforced to the fullest extent
              permitted by law.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The validity of this Agreement and the interpretation and performance of all of its terms shall be governed by the substantive and procedural laws of the State of Utah.&#160; Each
              party expressly submits and consents to exclusive personal jurisdiction and venue in the courts of Utah County, State of Utah or in any Federal District Court in Utah.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement, the Key Employee Covenants Agreement, the Severance Policy, the agreements related to the Company&#8217;s deferred compensation plan, the Company&#8217;s 401(k) plan, and
              Employee&#8217;s stock option agreements (the &#8220;Sole Agreements&#8221;), constitute the entire and sole agreements between Employee and the Company and its affiliates.&#160; No other promises or agreements have been made to Employee or the Company other than
              those contained in the Sole Agreements. Employee and the Company acknowledge that they have read this Agreement carefully, fully understand the meaning of the terms of this Agreement, and are signing this Agreement knowingly and voluntarily.&#160;
              This Agreement may not be modified except by an instrument in writing signed by all of the parties hereto.</div>
            <div>&#160;</div>
            <div style="text-align: center; font-style: italic;">[Signature page follows]</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%5%%%-->
            <div>IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first set forth above.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z115e689b955440bc856055e765ccc1d1">

                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">
                    <div style="text-align: justify;">NU SKIN ENTERPRISES, INC.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: justify;">By:</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">
                    <div style="text-align: justify;">Its:</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="z52d5ddc5dee94973a4cf4628996488d0">

                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">
                    <div style="text-align: justify;">EMPLOYEE</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
            <div><br>
            </div>
          </div>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT B</u></div>
        <div>&#160;<br>
          <div style="text-align: center;">KEY EMPLOYEE COVENANTS AGREEMENT</div>
          <div><br>
          </div>
          <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></font><font style="font-size: 10pt;"> &#8220;Employee&#8221;</font></div>
          <div style="text-align: justify;">(PRINT NAME)</div>
          <div><br>
          </div>
          <div style="text-align: justify;">Nu Skin Enterprises, Inc. and its affiliated companies (&#8220;Company&#8221;) operate in the highly competitive direct selling marketplace competing for product market share as well as recruitment and retention of
            independent distributors.&#160; The success of Company depends on maintaining a competitive edge in this industry through the introduction of innovative products and attracting and retaining distributors. Accordingly, as a condition of and in
            consideration of employment or continued employment with Company and participation in the Executive Severance Policy maintained by Company, the parties hereby acknowledge and agree as follows.</div>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z681757c25ed949ae8a08a185b626530d">

              <tr>
                <td style="width: 36pt; vertical-align: top;">1.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Conflict of Interest</u></font><font style="font-size: 10pt;">:&#160; During employment with Company, Employee shall not have any personal interest that is
                      incompatible with the loyalty and responsibility owed to the Company.&#160; Employee must discharge his/her responsibility solely on the basis of what is in the best interest of Company and independent of personal considerations or
                      relationships. Employee shall maintain impartial relationships with vendors, suppliers and distributors. Should Employee have any questions regarding this matter, Employee should consult with his/her director or supervisor.&#160; If any
                      conflict of interest or potential conflict of interest arises, the Employee must notify his director or supervisor and seek an appropriate waiver or resolution of such conflict of interest. Although it is difficult to identify every
                      activity that might give rise to a conflict of interest, and not by way of making an all-inclusive list, the following provisions apply to common areas for potential conflicts of interests:</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd15bb27da8bc4bb68cfbb19a5394bd9b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">1.1</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Related Party Transactions.</font><font style="font-size: 10pt;">&#160; Employees should not have a direct or indirect ownership or financial interest in vendors
                      of Company nor any company doing or seeking to do business with Company. Employees should also not have a financial or other interest in any transaction involving the Company.&#160; In the event such a conflict arises, the Employee must
                      notify his/her director or supervisor and the Company may not do business with such vendor or enter into any such transaction unless it has been approved in accordance with the Company&#8217;s policy with respect to related party
                      transactions.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8fac32753a54994bfb0a989b79786bc">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">1.2</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Other Employment.</font><font style="font-size: 10pt;">&#160; Employee shall not perform services of any kind for any entity doing or seeking to do business with
                      Company. As to employment with or service to another company, Employee shall not provide service to any company that competes with the Company, and shall not allow any such activity to detract from his/her job performance, use
                      Company&#8217;s time, resources or personnel, or require such long hours to affect his/her physical or mental effectiveness.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">1</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7a0557f4a1642b79f2c94247c284fcb">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">1.3</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Distributorships.</font><font style="font-size: 10pt;">&#160; While employed by Company and for a period of three (3) months after termination of an employment
                      relationship with Company, Employee shall not directly or indirectly own any interest in a Company distributorship or similar account.&#160; Additionally, during the course of employment, neither the Employee&#8217;s spouse, nor any member of
                      the Employee&#8217;s household shall own any interest in, or otherwise be associated with, a Company distributorship without the prior written consent of the Company. Employee&#8217;s spouse, or significant other living in the same household,
                      will not, without the prior written consent of the Company, own any interest in, or otherwise be affiliated with, another direct sales distributorship or be employed by another direct sales or multilevel marketing company.&#160; Any
                      pre-existing ownership interests or employment covered in this paragraph must be disclosed to the Company at the time of the execution of this Agreement.&#160; Employee shall disclose to his/her immediate director or supervisor any and all
                      areas posing a potential or actual conflict of interest.&#160; Said disclosure shall be made as promptly as possible after such conflict arises.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7463b61f26c40cc92248350c6862655">

              <tr>
                <td style="vertical-align: top; width: 36pt;">2.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Work Product</u></font><font style="font-size: 10pt;">:</font></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9c0bb58d45fb4a2e89e6ef0318dee938">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">2.1</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Company shall have the sole proprietary interest in the work product of Employee created&#160; during his/her employment with Company (&#8220;Work Product&#8221;), and Employee expressly assigns to Company or its designee all rights, title and
                    interest in and to all copyrights, patents, trade secrets, improvements, inventions, sketches, models and all documents related thereto, manufacturing processes and innovations, special calibration techniques, software, service code,
                    systems designs and any other Work Product developed by Employee, either solely or jointly with others, where said Work Product relates to any business activity or research and development activity in which Company is involved or plans
                    to be involved at the time of or prior to Employee&#8217;s creating such Work Product, or where such Work Product is developed with the use of Company&#8217;s time, material, or facilities; and Employee further agrees to disclose any and all such
                    Work Product to Company without delay.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z72cdc9c709084056bb1da1b9acc6e3a2">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">2.2</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Employee will promptly disclose to the Company all Work Product, whether or not patentable or registrable under patent, copyright or similar statutes, made or conceived or reduced to practice or learned by Employee, either alone or
                    jointly with others, during the period of his/her employment that (i) at the time of conception or reduction to practice are related to the actual or demonstrably anticipated business of the Company, (ii) result from tasks performed by
                    Employee for the Company, or (iii) are developed on any amount of the Company&#8217;s time or result from the use of premises or property (including computer systems and engineering facilities) owned, leased, or contracted for by the Company
                    (collectively, &#8220;Inventions&#8221;).</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1d85b406156f40c19edbbfb15522012b">

              <tr>
                <td style="width: 36pt; vertical-align: top;">3.</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Disclosure and Assignment</u></font><font style="font-size: 10pt;">:</font></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb24bc7f9996440e1a9112446ac53b18f">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">3.1</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Employee acknowledges that during the term of employment with Company he/she may develop, learn and be exposed to information about Company and its business, including but not limited to formulas, business plans, financial data,
                    vendor lists, product and marketing plans, distributor lists, and other trade secrets which information is secret, confidential and vital to the continued success of Company (&#8220;Confidential Information&#8221;).&#160; All Confidential Information
                    and/or Inventions, as well as all intellectual property rights therein, are and shall be the sole property of the Company.&#160; Employee hereby assigns and agrees to assign to the Company any rights he or she may have or acquire in such
                    Confidential Information and/or Inventions.</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb5f61de31a77464a858d81e5e058a3da">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">3.2</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>During and after Employee&#8217;s employment, Employee shall hold the Confidential Information and/or Inventions in confidence and shall protect them with utmost care. Employee shall not disclose, copy, remove from the Company&#8217;s premises,
                    or permit any person to disclose or copy any of the Confidential Information and/or Inventions, and Employee shall not use any of the Confidential Information and/or Inventions, except as necessary to perform his/her duties as an
                    employee of Company.&#160; In the event that Employee has or has had access to any confidential information belonging to any third party, including but not limited to any of Employee&#8217;s previous employers, Employee shall hold all such
                    confidential information in confidence and shall comply with the terms of any and all agreements between Employee or Company and the third party with respect to such confidential information. Upon hire, Employee shall disclose to
                    Company the existence of agreements Employee has with prior employers.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z22b408b75b8243ffad49e4b19e62e466">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">3.3</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>This Agreement will not be interpreted to prevent the use or disclosure of information that (i) is required by law to be disclosed, but only to the extent that such disclosure is legally required, (ii) becomes a part of the public
                    knowledge other than by a breach of an obligation of confidentiality, or (iii) is rightfully received from a third party not obligated to hold such information confidential.&#160; The Defend Trade Secrets Act provides immunity to individuals
                    under any federal or state trade secret law for the disclosure of a trade secret that is made: (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney for the sole purpose of
                    reporting or investigating a suspected violation of law; or (ii) in a complaint or other document filed in a lawsuit or other proceedings, if such filing is made under seal.&#160; If an individual files a lawsuit against his or her employer
                    alleging retaliation for reporting a suspected violation of law, the individual may disclose the trade secret to his or her attorney.&#160; The individual may also use the trade secret information in the court proceedings, provided that he
                    or she files any documents containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54da5e6f98264d6bacd75f5a65e31f61">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">3.4</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Upon Company&#8217;s request, and in any event upon termination of Employee&#8217;s employment for any reason, Employee shall promptly return to Company all materials in his/her possession or control that represent, contain or reasonably could
                    contain Confidential Information and/or Inventions, including but not limited to passwords, documents, drawings, diagrams, flow charts, computer programs, memoranda, notes, and every other medium, and all copies thereof.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7e2ce691ee864b529f902acf5d881aad">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 36pt; vertical-align: top;">3.5</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>Subject to Paragraph 17 below, during and after Employee&#8217;s employment, regardless of the circumstances of Employee&#8217;s termination, Employee shall not communicate to, or use for his/her benefit, or for the benefit of any person, firm,
                    or other entity, without the prior approval of the Company, any Confidential Information or information about Inventions; provided, however, that Employee may communicate such information as required pursuant to law or as necessary or
                    appropriate in connection with any suit or action, or any potential suit or action, brought by Employee against the Company in connection with his/her employment relationship with the Company. Except as outlined in Paragraph 17 below,
                    Employee must advise Company prior to disclosure of Confidential Information to be communicated pursuant to law or in connection with a suit or action as described above so that the Company may obtain a protective order as necessary to
                    protect its confidentiality interests. Employee will return to Company all Company-owned materials including, without limitation, computer and office equipment, supplies and internal Company manuals, customer lists and information,
                    passwords, and marketing materials.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf250f193d3ba48d09ddb275d6571e64f">

              <tr>
                <td style="width: 36pt; vertical-align: top;">4.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Future Inventions</u></font><font style="font-size: 10pt;">:&#160; Employee recognizes that Inventions relating to his/her activities while working for Company
                      and conceived or made by Employee, whether alone or with others, within one year after termination of Employee&#8217;s employment may have been conceived in significant part while employed by Company.&#160; Accordingly, Employee agrees that such
                      Inventions shall be presumed to have been conceived during Employee&#8217;s employment with Company and are to be, and hereby are, assigned to Company unless and until Employee has established the contrary.</font></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z726846d31b4c483aa5da41d4726815fe">

              <tr>
                <td style="width: 36pt; vertical-align: top;">5.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Cooperation</u></font><font style="font-size: 10pt;">:&#160; Employee shall assist Company in every way deemed necessary or desirable by the Company (but at the
                      Company&#8217;s expense) to obtain and enforce patents, copyrights, trademarks and other rights and protections relating to any Confidential Information and Inventions in any and all countries, and to that end Employee will execute all
                      documents for use in obtaining and enforcing such patents, copyrights, trademarks and other rights and protections as Company may desire, together with any assignments thereof to Company or persons designated by it.&#160; If Company is
                      unable for any reason to secure Employee&#8217;s signature to any document required to apply for or execute any patent, copyright, mask work or other applications with respect to any Inventions (including improvements, renewals, extensions,
                      continuations, divisions or continuations in part thereof), Employee hereby irrevocably designates Company and its duly authorized officers and agents as Employee&#8217;s agents and attorneys-in-fact for and on Employee&#8217;s behalf to execute
                      and file any such application and to do all other lawfully permitted acts to further the prosecution and issuance of patents, copyrights, mask works or other rights thereon with the same legal force and effect as if executed by
                      Employee.&#160; Employee&#8217;s duty to assist Company extends to enforcement of patents, copyrights, trademarks, and other rights and protections described above, of which were executed and signed on Employee&#8217;s behalf pursuant to Employee&#8217;s
                      designation of Company for signatory authority.&#160; Employee&#8217;s obligation to assist Company shall continue beyond the termination of his/her employment, but Company shall compensate him/her at a reasonable rate after his/her termination
                      for time actually spent by Employee at Company&#8217;s request on such assistance.</font></div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5e3c2038622f4e088989a36b91c6aa5e">

              <tr>
                <td style="width: 36pt; vertical-align: top;">6.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Ethical Standards</u></font><font style="font-size: 10pt;">:&#160; Employee agrees to maintain the highest ethical and legal standards in his/her conduct, to be
                      scrupulously honest and straight-forward in all of his/her dealings and to avoid all situations which might project the appearance of being unethical or illegal.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24078b8c60f041b59f97bfefe26a9d79">

              <tr>
                <td style="width: 36pt; vertical-align: top;">7.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Product Resale</u></font><font style="font-size: 10pt;">:&#160; As an employee of Company, Employee may receive Company products and materials either at no
                      charge or at a discount as specified from time to time by Company in its sole discretion.&#160; Employee agrees that the products received shall be used strictly in accordance with the policies of the Company regarding products received by
                      employees from the Company and shall not be sold, distributed or transferred in any manner that would violate such policies, as they may be amended from time to time.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z65729aa809ce418d93fa7a72669eeb08">

              <tr>
                <td style="width: 36pt; vertical-align: top;">8.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Gratuities</u></font><font style="font-size: 10pt;">:&#160; Employee shall neither seek nor retain gifts, gratuities, entertainment or other forms of
                      compensation, benefit, or persuasion from suppliers, distributors, vendors or their representatives without the consent of a Company Vice President with the exception of meals provided in the ordinary course of business on an
                      infrequent basis.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11ea05c30c5d4967b38fffe8a0c3dc97">

              <tr>
                <td style="width: 36pt; vertical-align: top;">9.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Solicitation</u></font><font style="font-size: 10pt;">:&#160; Employee shall not in any way, directly or indirectly, at any time during employment or within
                      two (2) years after either a voluntary or involuntary employment termination: (a) solicit, divert, take away, or unreasonably interfere with Company&#8217;s distributors; (b) in any manner solicit, divert, take away, or interfere
                      unreasonably with Company&#8217;s employees or vendors; or (c) assist any other person(s) in any manner&#160; in an attempt to do any of the foregoing.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd56c3749ff0435f8cc1f3d80cb78a27">

              <tr>
                <td style="width: 36pt; vertical-align: top;">10.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Disparagement</u></font><font style="font-size: 10pt;">:&#160; Subject to Paragraph 17 below, employee shall not in any way, directly or indirectly at any
                      time during employment or after either voluntary or involuntary employment termination, disparage Company, Company products or Company Distributors.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8a88eccc77d64b24bd716c2f1efe9dae">

              <tr>
                <td style="width: 36pt; vertical-align: top;">11.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Endorsement</u></font><font style="font-size: 10pt;">:&#160; Employee shall not in any way, directly or indirectly, at any time during employment or within
                      one (1) year after either a voluntary or involuntary employment termination endorse any sales compensation plan of another company or product that competes with products of Company, promote or speak on behalf of any company whose
                      products compete with those of Company, or allow Employee&#8217;s name or likeness to be used in any way to promote any company or product that competes with Company or any products of Company.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zee886e6788b84a86b6d60f918aec85ed">

              <tr>
                <td style="width: 36pt; vertical-align: top;">12.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Competition</u></font><font style="font-size: 10pt;">:&#160; Because of the Company&#8217;s legitimate business interest, in exchange for the benefits of
                      continued employment by Company and participation in the Executive Severance Policy maintained by Company, Employee shall not accept employment with, contribute Employee&#8217;s knowledge, engage in or participate, directly or indirectly,
                      individually or as an officer, director, employee, shareholder, consultant, partner, joint venturer, agent, equity owner, distributor or in any other capacity whatsoever, with any entity engaged in the same or similar business as the
                      Company, including those engaged in the business of LED light source growing, or direct selling that competes with the business of Company whether for market share of products or for independent distributors in a territory in which
                      Company is doing business; provided, however, Employee may own publicly-traded securities of a company&#8217;s whose securities are publicly traded on either the NYSE, American or NASDAQ stock exchanges if the Employee&#8217;s ownership interest
                      is less than 1% of the total outstanding securities of such company.&#160; The Employee shall not engage in activities that may require or inevitably require disclosure of trade secrets, proprietary information, or Confidential
                      Information.&#160; The restrictions set forth in this paragraph shall remain in effect during the Employee&#8217;s employment with Company and during a period of one (1) year following the Employee&#8217;s termination<font style="font-weight: bold;">&#160;</font>of<font style="font-weight: bold;">&#160;</font>employment.&#160; Within fifteen (15) days of termination of Employee&#8217;s employment, Company shall notify Employee whether it elects to enforce the Employee&#8217;s obligation set forth in this paragraph.
                      Notwithstanding the foregoing, in the event Company decides, in its sole discretion, to enforce Employee&#8217;s non-competition obligation(s) with regard to an Employee whose employment ended as a result of the Employee&#8217;s voluntary
                      termination of employment without Good Reason (as defined in the Executive Severance Policy maintained by Company), Company may elect, in its sole discretion, to pay Employee a sum of up to seventy-five percent of the Employee&#8217;s
                      annual base salary at termination of employment, less applicable withholding taxes, for the one year period following the termination of employment during which the restrictive covenants in this paragraph remain in effect. Unless
                      other arrangements are made at Company&#8217;s sole discretion, such payment may be made in equal periodic installments in accordance with Company&#8217;s regular payroll practices until all payments are completed. Such ongoing payments shall be
                      contingent upon Employee&#8217;s ongoing compliance with his/her continuing obligations under this Agreement.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z92217177c0e04ca38eeae7f13e3f1176">

              <tr>
                <td style="width: 36pt; vertical-align: top;">13.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Acknowledgement</u></font><font style="font-size: 10pt;">:&#160; Employee acknowledges that his/her position and work activities with the Company are &#8220;key&#8221; and
                      vital to the on-going success of Company&#8217;s operation in each product category and in each geographic location in which Company operates. In addition, Employee acknowledges that his/her employment or involvement with any other entity
                      or company engaged in the business of LED light source growing, or direct selling or multilevel marketing would create the impression that Employee has left Company for a &#8220;better opportunity,&#8221; which could damage Company by this
                      perception in the minds of Company&#8217;s employees, independent distributors, or other persons. Therefore, Employee acknowledges that his/her confidentiality, non-solicitation, non-disparagement, non-endorsement and non-competition
                      covenants are fair and reasonable and should be construed to apply to the fullest extent possible by applicable laws.&#160; Employee has carefully read this Agreement, has consulted with independent legal counsel to the extent Employee
                      deems appropriate, and has given careful consideration to the restraints imposed by the Agreement. Employee acknowledges that the terms of this Agreement are enforceable regardless of the manner in which Employee&#8217;s employment is
                      terminated, whether voluntary or involuntary. In the event that Employee is to be employed as an attorney for a competitive business, Company and Employee acknowledge that paragraph 12 is not intended to restrict the right of the
                      Employee to practice law in violation of any applicable rules of professional conduct.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z62246c7fb7094252b2e8ce83941f1627">

              <tr>
                <td style="width: 36pt; vertical-align: top;">14.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Return of Equipment and Information upon Termination</u></font><font style="font-size: 10pt;">:&#160; Upon termination of employment, Employee shall return to
                      Company all assets and equipment of Company along with any Confidential Information and Work Product including any distributor and vendor contact information and notes or summaries of all of the above.&#160; Employee shall not retain any
                      copies of the returned items.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z47f9fa3c816047f3b68756118982de9f">

              <tr>
                <td style="width: 36pt; vertical-align: top;">15.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Remedies</u></font><font style="font-size: 10pt;">:&#160; Employee acknowledges: (a) that compliance with the restrictive covenants contained in this Agreement
                      are necessary to protect the business and goodwill of Company and (b) that a breach will result in irreparable and continuing damage to Company, for which money damages may not provide adequate relief. Consequently, Employee agrees
                      that, in the event that he/she breaches or threatens to breach these restrictive covenants, Company shall be entitled to both: (1) a preliminary or permanent injunction to prevent the continuation of harm and (2) money damages insofar
                      as they can be determined. Nothing in this Agreement shall be construed to prohibit Company from also pursuing any other remedy, the parties having agreed that all remedies are cumulative.&#160; It is further recognized and agreed that the
                      covenants set forth herein are for the purpose of restricting Employee&#8217;s activities to the extent necessary for the protection of the legitimate business interests of Company and that Employee agrees that said covenants do not and
                      will not preclude him/her from engaging in activities sufficient for the purposes of earning a living.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z71e8d36d1aa545a5b11ab68d9b300758">

              <tr>
                <td style="width: 36pt; vertical-align: top;">16.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Attorney&#8217;s Fees</u></font><font style="font-size: 10pt;">:&#160; If any party to this Agreement breaches any of the terms of this Agreement, then that party
                      shall pay to the non-defaulting party all of the non-defaulting party&#8217;s costs and expenses, including reasonable attorney&#8217;s fees, incurred by that party in enforcing the terms of this Agreement.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z67d08602b26e4459903be3c82282757b">

              <tr>
                <td style="width: 36pt; vertical-align: top;">17.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Protected Activity. </u></font><font style="font-size: 10pt;">Nothing in this document is intended, or should be interpreted, to restrict, impede, or
                      otherwise limit the rights of all employees, including Key Employees, to report possible violations of law or regulation to any governmental agency or entity tasked with enforcing such laws and regulations, including but not limited
                      to the United States Department of Justice, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Department of Labor, Congress, and any agency Inspector General, or participate in an investigation
                      by any such administrative agencies; nor is this document intended to limit employees&#8217; rights to discuss among themselves or others wages, benefits, and other terms and conditions of employment or workplace matters of mutual concern,
                      as protected by the National Labor Relations Act.&#160; Employee is not required to notify the Company of his or her intention to file such a report or participate in such an investigation prior to contacting the agency.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7e740aa7d924335a7dce87716b35206">

              <tr>
                <td style="width: 36pt; vertical-align: top;">18.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Court&#8217;s Right to Modify Restriction</u></font><font style="font-size: 10pt;">:&#160; The parties have attempted to limit the Employee&#8217;s right to compete only to
                      the extent necessary to protect Company from unfair competition. The parties recognize, however, that reasonable people may differ in making such a determination. Consequently, the parties agree that, if the scope or enforceability of
                      the restrictive covenants contained in this Agreement is in any way disputed at any time, a court or other trier of fact may modify and enforce the covenants to the extent that it believes to be reasonable under the circumstances
                      existing at that time.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z29da53aac2b442e4ac2ba2d44de975e5">

              <tr>
                <td style="width: 36pt; vertical-align: top;">19.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Severability</u></font><font style="font-size: 10pt;">:&#160; If any provision, paragraph, or subparagraph of this Agreement is adjudged by any court or
                      administrative agency to be void or unenforceable in whole or in part, this adjudication shall not affect the validity of the remainder of the Agreement, including any other provision, paragraph, or subparagraph. Each provision,
                      paragraph, and subparagraph of this Agreement is severable from every other provision, paragraph, and subparagraph and constitutes a separate and distinct covenant.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z00f4b71333e446c2aff09d451e1b88b0">

              <tr>
                <td style="width: 36pt; vertical-align: top;">20.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Governing Law and Forum</u></font><font style="font-size: 10pt;">:&#160; This Agreement shall be governed and enforced in accordance with the laws of the State
                      of Utah, and any litigation between the parties relating to this Agreement shall be conducted in the courts of Utah County or Salt Lake City where necessary for federal court matters.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z39ad7e7bfe6f4460a4f9163279c307ff">

              <tr>
                <td style="width: 36pt; vertical-align: top;">21.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Employment At Will</u></font><font style="font-size: 10pt;">:&#160; Employee understands that employment with Company is at-will, meaning that employment with
                      Company is completely voluntary and for an indefinite term and that either Employee or Company is free to terminate the employment relationship at any time, with or without cause or advance notice, provided that termination is not
                      done for an unlawful or discriminatory purpose.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z078bf56cccd043a29435732609062791">

              <tr>
                <td style="width: 36pt; vertical-align: top;">22.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Employment Subject to Company&#8217;s Policies and Procedures</u></font><font style="font-size: 10pt;">:&#160; The Parties acknowledge and agree that Company has
                      established, and may establish, various workplace policies and procedures, which the Company may modify in its sole discretion from time to time.&#160; Employee acknowledges such policies and procedures, and agrees to abide by such
                      policies and procedures as they may be implemented or modified from time to time.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6983c98f929641129a66ffba917526cf">

              <tr>
                <td style="width: 36pt; vertical-align: top;">23.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Entire Agreement</u></font><font style="font-size: 10pt;">:&#160; Company and Employee understand and agree that this Agreement shall constitute the entire
                      agreement between them regarding the subject matter contained herein, and that all prior understandings or agreements regarding these matters are hereby superseded and replaced, including, without limitation, the Key-Employee
                      Covenants Agreement previously signed by the parties.&#160; Any amendment to or modification of this Agreement must be in writing signed by the parties hereto and stating the intent of the parties to amend or modify this Agreement.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z50714bab462c466199a154734c594aeb">

              <tr>
                <td style="width: 36pt; vertical-align: top;">24.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Survivability of Obligations</u></font><font style="font-size: 10pt;">:&#160; This Agreement sets forth several obligations which continue after the termination
                      of Employee&#8217;s employment with Company, including without limitation those obligations set forth in paragraphs 1, 2, 3, 4, 5, 6, 9, 10, 11, and 12, and the Parties specifically acknowledge and agree that such obligations shall survive
                      the termination of Employee&#8217;s employment for any reason.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z39ad104365e44a9e96ca92670709fb7e">

              <tr>
                <td style="width: 36pt; vertical-align: top;">25.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Enforcement of Restrictive Covenants</u></font><font style="font-size: 10pt;">:&#160; If Employee breaches any of the provisions of Paragraphs 3, 9, 10, 11, or
                      12 of this Agreement, the Parties acknowledge and agree that such breach is likely to cause the Company serious, immediate and irreparable damage.&#160; Accordingly, if Employee breaches or threatens to breach any such provision, the
                      Company shall have no adequate remedy at law and may obtain injunctive relief against Employee in any court of competent jurisdiction.&#160; The seeking and/or obtaining of such injunctive relief shall be without prejudice to the Company&#8217;s
                      right to seek any other remedies available to the Company for such breach or threatened breach, including the recovery of damages from Employee.&#160; Employee agrees that the Company does not need to post a bond to obtain an injunction
                      and waives Employee&#8217;s right to require such a bond.&#160;&#160; The remedies provided for under this provision are intended to be in addition to, not in place of, remedies available under federal and state laws, including the Federal Defend
                      Trade Secrets Act (&#8220;FDTSA&#8221;).&#160; If the Company pursues claims against Employee under the FDTSA, the Company may recover damages from Employee that include, but are not limited to, monetary damages and punitive or exemplary damages and
                      may obtain injunctive relief against Employee.</font></div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div>THIS AGREEMENT HAS BEEN READ, UNDERSTOOD AND FREELY ACCEPTED BY:</div>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z27618b0ada50466b9741451d006aed91">

              <tr>
                <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 25%; vertical-align: top; padding-bottom: 2px;"><br>
                </td>
                <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
                  <div>Dated:</div>
                </td>
                <td style="width: 17%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 29%; vertical-align: top; padding-bottom: 2px;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="2" style="vertical-align: top;">
                  <div>Employee</div>
                </td>
                <td colspan="3" style="vertical-align: top;"><br>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div><font style="font-size: 8pt;"><br>
            </font> </div>
          <div style="text-align: center;"><font style="font-size: 8pt;">9</font><br>
          </div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>nus-20201015.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://nuskin.com/20201015" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nus="http://nuskin.com/20201015" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="nus-20201015_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="nus-20201015_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://nuskin.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>nus-20201015_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>nus-20201015_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://nuskin.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="nus-20201015.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://nuskin.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>brhc10016052_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nus-20201015.xsd" xlink:type="simple"/>
    <context id="c20201015to20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001021561</identifier>
        </entity>
        <period>
            <startDate>2020-10-15</startDate>
            <endDate>2020-10-15</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20201015to20201015"
      id="Fact_8dbd2699d2e4444286e282352ec98c3d">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20201015to20201015"
      id="Fact_8ef496a892794eb4927adc4f8c76e8d8">0001021561</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20201015to20201015"
      id="Fact_8da9aac50b354fb39b6968f88059ef9d">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20201015to20201015"
      id="Fact_055bcfa46dd94f1fa40e7e92e7d399f8">2020-10-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20201015to20201015"
      id="Fact_4b2d3484934c47878b9d9b4999ce3c28">NU SKIN ENTERPRISES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20201015to20201015"
      id="Fact_7241a0acc4c948dea60b6ffe9ad21273">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20201015to20201015"
      id="Fact_4e96305dfcce4ec59ebe8da70818c785">001-12421</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20201015to20201015"
      id="Fact_ad535828e7cb4ef89d7d0b8cb37c701b">87-0565309</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20201015to20201015"
      id="Fact_114703ad83f34578b2d272f717163c48">75 West Center Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20201015to20201015"
      id="Fact_4dd029fd3db14b0a8f9ddac5a31ba1d3">Provo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20201015to20201015"
      id="Fact_4d4d6b125c2a422fb17de756cb5b3b15">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20201015to20201015"
      id="Fact_468b32d651104793a4195d46a205564d">84601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20201015to20201015"
      id="Fact_4887830c26de48318e2d07eddf5ce18f">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20201015to20201015"
      id="Fact_cffc4c4e3f424f7cb7814953659b0741">345-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20201015to20201015"
      id="Fact_9ff55eb04d6141329b6322aa62f500ae">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20201015to20201015"
      id="Fact_bb11bce8095441b5a533f760624911ae">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20201015to20201015"
      id="Fact_8fe41d7e3a4b47dab49567e5fc326cc5">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20201015to20201015"
      id="Fact_a8e76693d58541878981559dba3a1307">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20201015to20201015"
      id="Fact_657cdce137a1475f85ea682f07abfe79">Class A Common Stock, $.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20201015to20201015"
      id="Fact_fd9a6b950b8b4e3b82653ce2e415072f">NUS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20201015to20201015"
      id="Fact_c6cc0d816d1b4a64b7f7682d541a49d7">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20201015to20201015"
      id="Fact_0889afb9b06f4c3396420b30557b71ba">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140354280574456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 15, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 15,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NU SKIN ENTERPRISES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0565309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">75 West Center Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Provo<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001021561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NUS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MI6J//X7W*+F?&^[_$L4/4$L#!!0    ( *J 5%&7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ JH!441PX9>H_ 0
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M 5!+ 0(4 Q0    ( *J 5%$'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ JH!44; <GBCN    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ JH!449E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " "J@%11:X;+*3<$  !($   &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ JH!448.II0/4 0  ,@8   T              ( !>@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " "J@%11EXJ[',     3 @  "P
M@ %Y#@  7W)E;',O+G)E;'-02P$"% ,4    " "J@%11'#AEZC\!   \ @
M#P              @ %B#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MJH!4420>FZ*M    ^ $  !H              ( !SA   'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ JH!44660>9(9 0  SP,  !,
M             ( !LQ$  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  _1(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10016052_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nuskin.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10016052_8k.htm">brhc10016052_8k.htm</File>
    <File>brhc10016052_ex10-1.htm</File>
    <File>brhc10016052_ex10-2.htm</File>
    <File>nus-20201015.xsd</File>
    <File>nus-20201015_lab.xml</File>
    <File>nus-20201015_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10016052_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10016052_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nus-20201015_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nus-20201015_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "nus-20201015.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "nus",
   "nsuri": "http://nuskin.com/20201015",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10016052_8k.htm",
      "contextRef": "c20201015to20201015",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://nuskin.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10016052_8k.htm",
      "contextRef": "c20201015to20201015",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-20-023403-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-20-023403-xbrl.zip
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MLOQGH(2RO3!4MF;PSPX\;0>VX]I:AH%T5$VZZ_)41Q\V9,-*939CJ@KD/FP
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M!-\F7<L2=2^AM/W;E_+_GL<E3#F&3R=I'2DL6C9;&$6NJX4%SCYEU+%#X3E
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M#.$UMJ(Z'?"_$S A_M)^*U8%HQ;@79&.L1*MY]NAVXI\Z,YM# .F_@Y\IW*
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M/L-H*W1+@5UTDK=)W<S=A&4N3G+D4;>L!IU<1+K<Q3_@(P,2P^88%YL+^6Z
M2 G6'4J%Y0!T7&K\%8P7S"I<\Q\Q&I^3G0[&WEM=HX8R@-L\T6*<8[,FB]"K
MM<$EX/'[>7&FI &K3A(4:B!CDG;L[>I/,CQRIE?%IK/$O@/$JA^=_,KW+/P5
M5JX!>.#E\S/704O8H$O10 H" PS :6D,A!P/]]E"<@N,Y^D\3H:S:!+/PCA9
M+A<JU?/1.-7C63I.OB;"_.6W> O J4DS]+V@PGZ ;HOUSJATUP]R252*_!P7
M[;,O4F(0H J62Z4\%*WDAH&CE[DN>/#(-L6QD4\#+^\Y@F?1$B2L%#>&38'Z
MWA9HIKH*VM)D6X)5E:.3$HMNJ0&L+CK]H*&*Q*_(!?R2PZ:+8/2!U/2\1S!#
MXKH] 2*]Q9;U1YM5\D=C([MU\8KY]2Z6XZ'H-VC]C\DQ@//TP<$58UQ*"CE>
MA@3*JC771Y%$_@8:UXC; =UH/3GYZ$) +^D:;C*I:-8;JM%<8L7/7MU6+J:_
M:V9,N0'%G@+*E/WW-BN-UP)M3F(3D(Z_AT56U(,]F01<ZK1_LG JY2E5KC*R
M1?^]Q8N>O[$CJ[>??I:O+IBL;9FWM0Y!._:._LE-Z2^[%)9+WPT&/VX9"__C
MU+524WBELQ72]R2^[5QABSUD4<![PS]8<M0J,.;+DCQ 9NT%)Y@47+ZAM#A
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MX@F->@&RRGV$:'XPMV%'N3-EF[0L(.8>NPRU4K6/6=.6:+"\J2SQQI44?37
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M8V\%M=T'/B:-LW4K!#6TT'\_W_DE=I)"NZX,"2202F@2^\X^GWW//9<7H6'
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M\<*\AH;ZLICT+6.6LWED.U6?PC*F_!.S7*:N ?/EY#?ER!E^VJ3O-7.*&U4
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M4;"^RPVON#3C+^'7N V#KM[0E; ;^>E](\Z2)7[X>7<]91_^ %!+ P04
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MP\UQ3J @! D<F)V!7C/PB94L<W/=(M 4X#=<8Y*+=?P=?F$OO>:=8J:LO[L
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M/<FM.R^TZH-Z[QIT-^]KC0J;JQ@V/?9N+LO8"LW:4(MBNO6T2-.\[[1 3?Q
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MKK];@<8P5%05-[[$JP31$2)*V^YH].[U]E4>E0:UX%00-W5*+<9#Y6*$=&K
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M+U;C22>YNUZ47:GI;NA;3ED-OK@4GO?$32BME(RK#$RX]S?8-"F7J[F(.!7
M2807MP<H%U*Y/LB2 ]97.KZP)6NV ,45O0B5C:@M3V- .2,HU/E.I:Z%&!R;
MRO7H,#V2XL.@2!=V*;@AOQ^=G;I[< 3#' ;G5Q1E<2J\S51#X_?O^ IP_3"K
MSGXGY0JF!#K%'(YC*70[$^=,3;<;BE*UC^QD@5T1>AA#F.B.4!BR+)+;AG4X
M#+XX=-=_ FP]I4\BM$@#.*#UWUUE-Z3"<-T6SL[FW!"L%Z;6PL'E"")8*5<K
MJJ%<^#/.R"K,'CW%J+<EW"M7(U-!:63\!3IEK"E/P8"24:$,@VTUX8FJ')4;
MXUD[+Y6"^ULIKCHZZS9 #["2PB9>Y93XDOM653+6\B9\FYO0H=91J7N5X OK
MG!5U?":<,5C!CU]EW]L2,9;QO/#6.YT3=$9]LC'!JZ,=7HH1:%['*>3F2SH!
MGAQN"M$!7XC2/%HOT#I"WI5B/=1ZR2HY[YG)"*!DP3_6>5K$[ MFMZ:?F*>H
MP*MVS55+X\J,E'[/EC W>"'&AUGM;!76,A]4QJ)G[I-GH3*T/P]QB091J3[D
M;@"]XNX F(N*'>#CG&%2W0&F\J1E/>3M.Q/<#-CZUQG6@\U)G6!0?^86]:\Z
M%:!Y@,I3]8;<21"!@TW%[5_T5S-;Y^39^?Z###FQ ]P[EJ>X>W>D5C*@!;*J
MPN=U*,/HY6K?L":GAY80-HO5]@#RY#8<5YEAVHX/\]5Q.S9T-$2ZYHD:#$"7
M<,XEI@!XM1KDXR\\4 "%$<E7<#YOPQ![BC,8;]K]XR4B@E8 ?IQC:,83( 6!
M'#H6W+)NA:E&4-8TY+M!#[0CL!)AA,U"I<-H3Y'V%*M "JI>U(/)/0 NZNA8
M6Y#!&U(-8:J?4_AC%](<':K!.$J(N@O>2!DKJ:HTS[@#0\TQ84A'QQ@-7VO#
M-D?%US->[<C=[<A>]]60W/;RJW-K!J<&E>;=S\?O?_OEF&$J'X#9>,]3AYF6
M\&;DHCD7NSRI)!T! 7F+E8C@;O[]3?<-_;W"J@?U-^\[_8KG_S^CP6B2)(/>
M;# 0PSB4LWZW-XVC;C>*9H/A:/S&H]5$@ %X^VWP'Q=407(J;X*S;"&6_^'!
M9/(E:CINA) 1JP(^HW]3[%9M"[HF:Z?O4UV% LN\0I/X6MR&\LDWVDR'/:%
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MTV*MI?EV:J<6>M>]4*F)+6Q@ZH2XS8>0@AF257)2KL5Q)46?B.IR/3<J,(T
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M'N\_&A6#&;@.SC\A)@S'*]"GVL&.FH=U+RP[G@7E(&BL&,?G3(G[V0KQ3TQ
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M#\)Q+^F/HV$7V\WUA]/!J!N-IQAJ&WVQ/M 8%/.5A/[+#[3]CE7T'SE\O4.
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M\+BIDBAV1I;Y4B]0A9R 2I#$1( ]"^JKVR<8J4E0,LM+6#LCJ%O6O,\8A)V
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MR$DJG\3PETUV9/LMT-HCNC.T\=06V#K<!'^>ZN".05!@EYD'Z"H"0Y?7TNE
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MFKJ-8K25?3$5;C5?(OXU(;,EFZ^OU#GA@<.TXR0'+U=%@=DZ$Z)80![/!_O
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MN\ERML!UWYN2R_0!;-Y(CLB4:XRKDV%*@>ZMX[M.X#JAZT2N,W"=V'52E\T
M^^OS*]8/Y%6KC0U1VZG %(5;+ ]4U#NC0&6AQ?6QWI(]J86V34NWUO%3NWR.
M1LX >.@S0S\>T"@B*4WC@J1!G'B)EU9Y\BB9Q8/CBE7+NI6!+PUF@=+T#G)T
M*BV\CQ.OW&F(N5_HHQQVSJ[=K^D'%D;]]X )>*1%V!8D9ZR_4IZ-@\-\IMW?
M4@0-@,$+<4?2D6?&L?'@*J7BHJ^#G0D@?]1]TV")'U/L3\/5N#O!J)!&R+F9
M+\Q(.(BH E!S)IP]F%L3Z\BK6+);&3'')H= :C"#1CDWW<N5I.>PM?]KU=1M
MR8E"9DY'*&XE*M2_ 0:)*EDO4UEN]JK\,5+Z,SL"7<Q4\DC68"?;9"@6$5;8
M6HLKP\UP2^H9KE:W85XNVM@.QN* B8$/NTE<*=*&N&NX4I%U")_8"G5O5/Y3
MJ0P7E--5YU2$S2U:#)Y<\&J@8KV(7C+[Q8LYGPA6ZK*SK&323\%<@G[$8#O9
M.<6L*7"[DG8I/W%JAZ+=:?*/N:$FTS*Q)ZXL-< 1MT7E]BT*;ULZTJ0)QYV$
MZ[-_*MX:TXK:X]>FF,=TPO.8 E'8>2FR(9V.IY.1R'_TZK665^:Z8(@B5!B8
MD1H(S^NG0[.6L#5W RH46Z1_>PA:%'X5Y77",?16D^1QXB!T$STALA$$]H"X
M#D<(*&-_@P:Q]H9M0O8Z_D]- 8$'TX^_3IS1A\LL^ST[FSH?1Q/G?9:=.9?9
M:.PZG\_&V>5D>GX^=D9G8^>4O?;IBS,Z.<DNIMG8>?_E)TNS#Z;^<$/PX30A
M85@R]6=&;EKVCORU14EJ_LQ?LJL3_KSZ69*\DM@?YAXIR<!CME>>)I$?#?S2
M\V)"RX=S@02#'_I5&?DE$I%@AC&6\2K7AKNQ%%OVVGX#$,MDCN#^W47[]693
MY]Z-(7M4S^[<<SA^\E]/?_JO37^/9-FV+]EA8 =U_O9%H([B?BKV.RD'#U@5
MU7FXH_/[??]#2E:;3C_D5L7&.,7EL .FW (,VKI*Y;6S>]R]@!WV]O8%[TU-
M_Z& 7,\'2' 5A*ZTWL2CAG?"G_$C!RCFG&Z >>:_]&_YZY<W^:*\PQ]7R^L9
M^_$/4$L#!!0    ( *J 5%'DVA+/;0,  'L0   0    ;G5S+3(P,C Q,#$U
M+GAS9+57VX[3,!!]1^(?3-[=)-M=H-5V$6AW$=*RH (2;\AUIJU%8@?;8=N_
MQW;J7'JC24%Y<>PY9XYGQA/G^LTJ2]%OD(H)/@GB010@X%0DC"\F0:$P492Q
MX,W-\V?7+S!^#QPDT9"@V1K=W;Y_.YVSU)@J]'GZR0P!O1I$]D'OI"")9,D"
M,+;@E1HKNH2,($WD O0CR4#EA,(D6&J=C\.0%^HGXP,JLO BNHCB*+XR6E+(
M@.M[(;-;F),BU9/@5T%2-F>0!,B(YVJ\4A7)T]/3X&DX$')A2*(X_/[QX8MS
MZVV-E^,>2S.SJ9\MTM5,IIYV&-KE&5%0*=BQWXB(1Z-1Z%8K4T/$CE SKC3A
M%)KVB:X 3>.KL%STIB9=>IU#O<$Y43-G[%<,*A[A*,;#V(.4U(=0U=(>&"^R
M_9M(M PMR$0W \EH!1#\!(S@> N7 &MO7@$=+,3OT"PT=9DB0\B6&>%<:*)-
M/;NIS62>,SX7FQDS9U,R]FF<PARY)(VMBDF@6):G-@-N;BEA/@E,L6!?)3]R
M"0,CSUM(D<*1E-KET$"4J60G[*'VZRF(I#LL.S5D2$0.4C.3DKH$PW^UJY3,
MNN[*0"#]O]NQ/%_-!I =?)M^V'=\G99;00O;+-[RY(YKIM<?3,9EYB(>()9,
M@J,6E5OO.($YX\P54F1Z210AC#Q#<TAX@DHZU."[#K=)MOD+!<DG?N/&V]6Q
M06],CB$I26F1]@#6R@[C-K,^!?Y A5LGJIQHGSM[ZDS!":D1W^GUS<:T("1O
M-9CR._$@J"-K'_Z]P!!2K?P,KJD&*Y7X>CHJYUA?V2M''0+9P=D*J"BXEFM+
M^*J3BB;0O^":I:>:0DIS)5AW#TH+6;V='1Y8T65W,17*C<X6P0FCJGN&:E@Y
M/#L[BE%+%W=2X4%V@&OTR0JV/P:CL@%S6-B[X<$3W(*E4K90V/+@^ +'+\_7
MH3MKT'W\MX.J<VFC^KI;*CS*C7"-[QV$YA7RE" XB'W#'F=#,;2A.$/%92CM
M;>!$ <[:NKW$T6L<1]TRL',=/M&K!UC'5_UVNO_F>HK_)O*Q!)Y]!';OWMV4
M])=Q_$^C_Q?=<?5IUKNM87,E-5*IQK#*4\*)%G)];]Y/;Q=-EKN:Y*R8F?^L
M[N'RH#)4]E>M1Y3^\JO74\CAI+F+8LEZ\P=02P,$%     @ JH!44;NB;?^>
M"   (%D  !0   !N=7,M,C R,#$P,35?;&%B+GAM;,V<76_;-A2&[P?L/W#>
MS0;4<6P#&Q(T+K(T+8*E29"DV!>&0I9H1Y@L!I3<./]^I"3:(GE(R14M"45;
ME^<]+RGR.:(DJWG[;K.*T%=,DY#$9X/QT?$ X=@G01@OSP;K9.@E?A@.WLV^
M_^[M#\/A1QQCZJ4X0/-7=/G^X_G](HR8-$%W][?L(T:_'AWS7^@W2KR AL$2
M#X<\F:G^.^5_S+T$(]9IG)QNDO!L\)2FSZ>CT<O+R]'+](C0Y6AR?#P>_?GI
M^L%_PBMO&,9)ZL4^'B"F/TVRQFOB>VDVXE+Z9DXC83 =;?LR*OB_AD(VY$W#
M\60X'1]MDF!0#)&':W0BY!M-7QS3^.3D9)1%MU)F%%JLMX?-9@^A?/XHB? ]
M7B#^]^?[*V/VR8@K1C%.K[TYCEB767KZ^HS/!DFX>HZP:'NB> '[1)1N;?CL
MG/#9&?_"9^?'G?.HR?"6'*5'DGJ1FW%F?OI8M6Z:#_K&U=3:AGSC<I99B>,6
M9KG43?-!WV$:DN R#@X_<+4K5X-_2#W: BIZ9\T/X/"C!H8:\:9K]DGJ%V]2
M' <X$#US;\NY,^LZ.]EFSEMOXDNN$=]%"-4/)V&NF6."_:,E^3H*<,B<QR?\
MPY!_&!Z/BYWB1];TY8*P+?1\GJ34\U/AEQW*V0",I6'*CT")C>3A\GQIP!0G
M9$U]K/2@C>!+-(_VFBIII?.AF4Q7$>N67QS@>/CY88#"P*2=94WH']'X[]O1
M;M3ZD9Y3>74\ZHLAL8\5AU$H1CYA6^9S.I2.:$')RK0.I&+ZBMG(_$Z1)$,I
M08;<44O<7<9L?*_G0<#(2(J_6/'@L4)(I:XX3(NN 9M&5U><5G5@8M:>-\O#
MJ B\$1\0EZ#;&'?+<_6:DCVF7^;<F"*8K_#LFO])3?XG-?F?'(3_R:'YGWPC
M_Y,:_#^^D'[R/ZG+_V1__B=5_$_ZP?^T)O_3FOQ/#\+_]-#\3[^1_VD=_MFR
M]70'F-:M@.G^%3"MJH!INQ5POF(W!NQW^B'RE@I[8*PX3"76@&[)R171D*F)
M8ET[VS8AWM8MI? JD(K)DVF49() (+<MZBXX^A1[%R10D8!"XFY/"C6YV2L9
M.;O7TSV-MWJJ=':1G2=9$^)M'=_G00M [!.GW.655-N;/"VSDSV>#^.6/I*7
MV+;#ZRIH?R^K7.WN.\^#[.V:?:V=7<G2]O6,7D(15_1H1P=6$=K/X2FW[.:[
M!' O5_VZX9RLXY2^6B&7)2#A0N(,[]SP,&Q+WO7 +J7H5.?!/@&MK!A(LS[#
M-I1S-<QQV:DMB-\3?\TO2;9?)[SW4I4JJZ8X6(.F <>@HRN0;>8FDLTY,Q%"
M>8RM>8!XM%N6[>M&:DZS3#,H%SA;O-H]*5_%/J'/A&;?N3^D;!1%<0'7OWMD
M2*?LBHS&9W"KO]L3>IVN[.?W:@=QNI>4;U"FY=<RXLS8_?7X/D"0;UHQ:(.P
M)LO[18U^VBHW_EY+=/=$8GRS7LTQ56@VA8L)T,,-JD8U<U4B!E]3/8#R6=:*
MLF:4MW?+N'%A2/5DRO2J2H$J[-#)M?D=25(O^CM\-I[];4+H.ET1NKI:EVP/
M<LT.]5#KREU/U*[?<PEBFMZ<Q*WK"EW-&U? <DTOY8!7]H!K)X60[16W](Z2
MKV&LX5A'"A6#)G55#HKQ00H"[J-624"I6E%LKV^$K$=E85ICJ# L:V$I#24+
M+ [0N:WR>,#^FK*QC"?S1WX8"I*F<''(>K@!^JJ9*]P-OB;$0?DL^XC( HTG
M/\U_1D+4+<S&U2'5,RI#JRH%J+!#6W#>D$?J\1?;'UY7<Q(!7QA:%,4!@HH&
ME )^KD U6YM8-67,;@@J(B@/]>!K1=M:D5J3*S,+B 6V1I^VR)6Z5R@"8\6A
M*;$&G$I.K@B%3$ULZMJ9C&2W-,*K0"HF3R90D@GV@-RV-_/+C?_$E@3?>"O3
MA@Y)E$U=ECC8V,N&KC=WP+MJ@]=29B*"1 CQ6#_V>'#!2+T)AO?ZLEK=[W6G
M=N_7[O$RY*]GQRG L$TBW9^IDL;W9;*AV_LQT-M^'P:DB/NO7:@'#%L7C-2;
M8.@F2U;+-U>04[L,7^"8]1]=Q0'>_([A;\8-&HEB3=,88\71+<>PN1UD*$>0
M7,10%D0LV@>63>M&:DXS1+,BEW$&O=KE^=';7 5L&.$BS/\O+_B-1RVMQ+=1
MVYAS@[-;WNV=V+FWY0K^F0;)HEY\@5)OG<F>RP'5A2%-K@^K=]OODGP($]^+
M_L(>_<!:$H7/"I7R/HFF<O!&B>+I^IT2V+[JK1(H:_=>21Y%/(RR>#_>+#&M
M(:D]X?#;)4J"^GX)Z-<-Y?FK+M6< SJ0=$GGC/62ZV%HUSNHQ[N:IQ%?O%#5
M.^:A]02I-TR]C?M2"DR^YMDV^X_,UX![.:00GH<<0,V-7'-<\JQ"=RO=T<J;
M^H&G-/_$/F\PA%RE<K?+; NU/VB8ICB^(*O5.BXN:M13K%53')Q!TX!"T-$5
MCC9S$Y?FG%D10G*L6U+MJT9J3K+,+B@7$%N\6GLT3:+0#],P7G[R4G;V]M1O
M1<P"\5@:$#1Y**W9.7LD;7(V/I"&$V:[=B0"'3^+-J\1J3.KRG-H3;M]"FUP
M:0O6.XIYK6 V$=FYG_\D&WJ[6&@/.ZJ%Q2';A T@-MNZ@KFR!Q/4%8DS%A_Z
M)0'*%2B3=(MYC54E^\R_C+TY1^!?Y=I1&5PER1K3VL5@E,,E <C=%89F?J#R
M,/53LTC@=+U4<EU_*\:\]'#=6)?'6CU:IJ&&##VT^P#]0QC!_TO %)8>DY?#
MC9^,[\S</@S7?.W/OQ6Y>.3-FWOTD!M8&%(]F="C[)U2?GJM.K3+Y>4*TR6[
MV/I(R4OZQ,KFV8OAKRNM2HE6@[(QN*"O6X9M7=AQ-F<*LH4"Y1)4:/I N7UM
MR5Z+ +$/)LEE8/$M?N)D:9ZNV2?^<XJ+IC#_N;ZS_P%02P,$%     @ JH!4
M4=?D4>GJ!0  F#\  !0   !N=7,M,C R,#$P,35?<')E+GAM;-5;:V_B.!3]
MOM+^ARSS.83 SLQ2E1FQ]"$TG1:UK/;Q9642 ]8D-G),H?]^[6"S.'$2TY>,
M1FHSN<?7]_B<Q.0VG'_=IHGW"&F&"!ZTPG:GY4$<D1CAQ:"USGR010BUOG[Y
M^:?S7WS_&F)( 8.Q-WOR+B^NA_=SE'!HYDWN[_@A]#ZW.^*?]SLE(*8H7D#?
M%X,YZL>9^#$#&?3XI#@[VV9HT%HRMCH+@LUFT][TVH0N@FZG$P9_?;]YB)8P
M!3["&0,X@BV/X\^R_.0-B0#+*SX8OIW11"7H!?NY*A'B?[Z"^>*4'W;]7MC>
M9G%+EBC"%I,H^+:$EYS"?K\?Y-$]E"="-:GWM/GJ>=YN_2A)X#V<>^+W'_?C
MRM']0" "#-D-F,&$3YD/9T\K.&AE*%TE4)U;4C@WYTDHW:<1J],7JQ-^$JOS
MX?_,P4O*6P@K30D#R>O4F><KUUJ:YN5%W[[6TM:5?/N:J\PO<?@.JWPPS<N+
MGD"*2'R)X[<OO#C5:Q7_P !]!ZN4)WLY@;>O^HA2\3K[@7 [(NDN\06)UBG$
M;(BY: RQIS&>$YKFNT)SS3P;+ZG;"3OAQ[R@^G2'!:XHS#@PC]SP$]I<<,L@
MCF&L9A.E/H]"/J.:,R&1-DTBMC]"RSID?)I<A Q&[05Y#&*(N+!A7QSXXL#O
MA'*+^\!/_3LB?.\?SC)&0<14OD3(,F@98[Q.0:D0"]ZI7+5D4YZW4*TI)(O5
M0WJMAW(.J5XWH)'*Q \U+<O[M40$*T!Y/C]:HF1O@SDE:=5ZDMK2#\L[\[0,
M'B.>/I+0&-)!JR,^Q/&!<TBIO,9JZLZ+3@XOQ+>7<<AKCD7=5PE8%'0TQN1J
M%&+N*5E7?(.4A:%2R]!Y+94%]QOH!;^S5UR;1DSA(BU@W-/8AHSE95M((37O
M.J_Y;KNZAPLD.&%V"]*BY'40N4AFB'N"6U!IT-N<0<K=.Q&YQS@B=$5H3I)_
MTF1P1-:8T:<1B<WJ6XW0S- PPE5O'$/4RBH-":5S?CT1YURA!-ZNTQFD1IN4
MPYHG#L.N&J"2@I7:AZ.EM!]/1-HIV(YC3A#-T:XC5Z-S U83O1+KJ@/LR%G9
MH3*5],:G$_'&,(XYW4S^XL_*,#3ZH@:G><*(<]4/S:2LO&!,(WWP^61]T+7T
M0=?2!]U3\D&1U#-]T-W[X+>3]4'/T@<]2Q_T3LD'15+/]$%O[X/^:?E@Q _O
MZ)1L<)T+RBB3!PY1CCN@DM Q^A\F49TB]]M^&H7\J>:.3BAY1+N_[E9ZH )J
M,D()ZK@;ZJD=8XE2)N4+]UN(NK5W#[JU]P0=8KPA*(CC^INI''4K4!F4WJ?2
M/I3U3TC&0/(/6E6VD>J )NT+0,<=4$?K&!\4\B@WN-]=%'O9D$)@T-\44G^
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M-^\\*"W5#3\AOA^_BX@?XOOD7_X#4$L! A0#%     @ JH!449<DJ8G%%@
MAH,  !,              ( !     &)R:&,Q,# Q-C U,E\X:RYH=&U02P$"
M% ,4    " "J@%11DCIA@7!R  !WD@( %P              @ 'V%@  8G)H
M8S$P,#$V,#4R7V5X,3 M,2YH=&U02P$"% ,4    " "J@%11IEQ%F"-V  !Q
MLP( %P              @ &;B0  8G)H8S$P,#$V,#4R7V5X,3 M,BYH=&U0
M2P$"% ,4    " "J@%11Y-H2SVT#  ![$   $               @ 'S_P
M;G5S+3(P,C Q,#$U+GAS9%!+ 0(4 Q0    ( *J 5%&[HFW_G@@  "!9   4
M              "  8X# 0!N=7,M,C R,#$P,35?;&%B+GAM;%!+ 0(4 Q0
M   ( *J 5%'7Y%'IZ@4  )@_   4              "  5X, 0!N=7,M,C R
C,#$P,35?<')E+GAM;%!+!08     !@ & (T!  !Z$@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
